Generex (GNBT) Announces Sales Agreement with Elias Shaker & Company

Chelsea Therapeutics (CHTP) Reports Phase III Trial of Northera Met Primary Endpoint and Achieved Highly Significant Symptomatic Benefits

CHARLOTTE, N.C., Sept. 20, 2010 (GLOBE NEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that preliminary analyses of its Phase III NORTHERA™ Study 301 met its primary endpoint. Treatment with Northera provided clinically meaningful and statistically significant improvement (p=0.003) in symptoms associated with neurogenic orthostatic hypotension (NOH), a chronic and often debilitating drop in blood pressure upon standing. Study results also showed that Northera was both safe and very well tolerated.

“We are extremely excited by these top-line results which provide validation of the safety and efficacy of Northera as a novel treatment for symptomatic neurogenic orthostatic hypotension, a serious condition for which there is an urgent need for improved treatments,” said Dr. Simon Pedder, president and CEO of Chelsea Therapeutics. “Symptoms of chronic neurogenic orthostatic hypotension are severe, not only putting patients at high risk for falls and associated injuries but also severely impacting their quality of life and generating significant added health care costs. Northera is the first and only drug to repeatedly demonstrate clinical improvement in these patients by both alleviating symptoms of neurogenic orthostatic hypotension and improving their ability to perform daily activities.”

Northera Trial Meets Primary and Multiple Secondary Endpoints

Patients randomized into this double-blind, placebo controlled study were evaluated for symptomatic and functional improvement using the orthostatic hypotension questionnaire (OHQ), which is specifically designed to rate the severity of symptoms resulting from low blood pressure and the degree those symptoms interfere with a patient’s ability to perform activities of daily living.

The OHQ is a two-part questionnaire that uses an 11-point scale (zero to 10) to assess the severity of six symptoms on the orthostatic hypotension symptom assessment scale (OHSA) and four patient function criteria on the orthostatic hypotension daily activities scale (OHDAS). The trial’s primary outcome measure, the composite OHQ score, reflects the average improvement (decrease) in mean OHSA and OHDAS scores.

Notably, in addition to the symptomatic and functional benefits registered on the OHQ, an analysis of blood pressure findings validate Northera’s unique mechanism of action and confirmed the preferential effect of Northera on standing systolic blood pressure versus supine systolic blood pressure. Northera demonstrated a statistically significant improvement in standing systolic blood pressure (SBP) (p< 0.001) relative to placebo with Northera patients reporting a mean increase of 11.2 mmHg compared to a mean change of 3.9 mmHg in standing SBP for the placebo group.This significant improvement was achieved with a relatively minor impact on supine blood pressure, with mean standing SBP for patients on Northera increasing 12% compared to only a 6% increase in mean supine SBP. Furthermore, no patients receiving Northera had SBP>200 mmHg during the comparative phase of the trial.

No Significant Adverse Events

As anticipated, Northera proved to be safe and well tolerated at all dose levels. Headache (7.4%) was the most common adverse event reported, with all cases considered mild. Consistent with prior study results, treatment with Northera was associated with fewer patient reported falls. In Study 301, all 3 patient-reported falls were in the placebo arm while no patients on Northera arm reported falling during the one-week treatment period.

Innovative Study of Symptomatic Benefit Conducted Under Special Protocol Assessment

Study 301 was a randomized, placebo-controlled Phase III trial designed to measure the efficacy of Northera in treating symptoms of neurogenic orthostatic hypotension in patients suffering from primary autonomic failure.

The study was conducted under a Special Protocol Assessment (SPA) granted by the FDA in February 2008. An SPA provides a binding agreement that the study design, including trial size, clinical endpoints and/or data analyses is acceptable to support regulatory approval. In addition to the SPA for Study 301, the FDA granted Fast Track designation to Chelsea’s pivotal program in NOH. Fast Track designation is designed to facilitate the review of products that address serious or potentially life-threatening conditions for which there is an unmet medical need and provides the option to file a New Drug Application (NDA) on a rolling basis. This permits the FDA to review the filing as it is received, expediting the review process.

The novel design of this multi-national, placebo-controlled trial consisted of an initial open-label dose titration followed by a 7-day open-label washout period prior to a 7-day double-blind randomized, placebo-controlled treatment period. During the open-label dose titration period, all patients were titrated to an optimal therapeutic dose of Northera, up to 600 mg t.i.d., and were required to demonstrate both a blood pressure and symptomatic improvement to be eligible for the blinded study. Once a patient’s individual optimal therapeutic dose was determined, each patient was taken off drug and washed out for a 7-day period. Patients were then randomized to either placebo (N=79) or Northera treatment (N=81) for one week. At the end of the one-week period, patients were evaluated for changes in symptomatic benefit as measured by the composite OHQ. The modified intent to treat population consisted of 160 patients (65 PD, 25 MSA, 54 PAF, 16 other) enrolled across a total of 65 U.S. and international sites.

Conference Call Today at 8:30 AM ET

Chelsea will discuss the Northera Phase III clinical trial results today, September 20, 2010, at 8:30 AM Eastern Time. Interested investors may participate in the conference call by dialing 877-638-9567 (domestic) or 720-545-0009 (international). A replay will be available for one week following the call by dialing 800-642-1687 for domestic participants or 706-645-9291 for international participants and entering passcode 12191422 when prompted. Participants may also access both the live and archived webcast of the conference call on Chelsea’s web site at www.chelseatherapeutics.com.

About Neurogenic Orthostatic Hypotension

It is estimated that over 100,000 patients in the U.S. suffer from chronic symptomatic NOH, a disorder of the nervous system associated with deficient release of norepinephrine, the neurotransmitter used by sympathetic autonomic nerves to send signals to the blood vessels and the heart. NOH is characterized by low blood pressure, lightheadedness, dizziness, blurred vision and fainting episodes upon standing and is commonly associated with Parkinson’s disease, multiple system atrophy and pure autonomic failure.

The only FDA-approved treatment for orthostatic hypotension has not been shown effective in alleviating the symptoms of the condition and is limited in its use by a pronounced side-effect profile.

About Northera™

Northera (droxidopa), the lead investigational agent in Chelsea Therapeutics’ broad pipeline, is currently in Phase III clinical trials for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) in patients with primary autonomic failure – a group of diseases that includes Parkinson’s disease, multiple system atrophy (MSA) and pure autonomic failure (PAF). Droxidopa is a synthetic catecholamine that is directly converted to norepinephrine (NE) via decarboxylation, resulting in increased levels of NE in the nervous system, both centrally and peripherally. Droxidopa is also being studied for the treatment of fibromyalgia and adult attention deficit disorder in two ongoing phase II trials and completed a phase II in intradialytic hypotension (IDH) study with positive results.

About Chelsea Therapeutics

Chelsea Therapeutics is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases. Chelsea’s most advanced drug candidate, Northera™ (droxidopa), is an orally active synthetic precursor of norepinephrine initially being developed for the treatment of neurogenic orthostatic hypotension. In addition to Northera, Chelsea is also developing a portfolio of metabolically inert oral antifolate molecules engineered to have potent anti-inflammatory and anti-tumor activity to treat a range of immunological disorders, including two clinical stage product candidates: CH-1504 and CH-4051. Preclinical and clinical data suggest superior safety and tolerability, as well as increased potency versus methotrexate (MTX).

This press release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include our need to raise operating capital, our history of losses, risks and costs of drug development, including clinical trials, risk of regulatory approvals, our reliance on our lead drug candidates droxidopa and CH-4051, reliance on collaborations and licenses, intellectual property risks, competition, market acceptance for our products if any are approved for marketing, reliance on key personnel including specifically Dr. Pedder.

CONTACT:  Chelsea Therapeutics
          Investor Relations
          Kathryn McNeil
          704-973-4231

RAE Systems (RAE) Signs Definitive Agreement to Be Acquired by Battery Ventures for $1.60 per Share

SAN JOSE, CA — (Marketwire) — 09/20/10 — RAE Systems Inc. (NYSE Amex: RAE), a leader in delivering innovative sensor solutions to serve industrial, energy, environmental, and government safety markets worldwide, signed a definitive agreement to be acquired for $1.60 per share in cash by an affiliate of Battery Ventures, a multi-stage investment firm focused on technology and innovation worldwide. The purchase price represents a premium of approximately 53.8% over RAE Systems’ closing share price on September 17, 2010, and a premium of approximately 85.1% over RAE Systems’ average closing share price for the 30 trading days ending on September 17, 2010.

This transaction is subject to customary closing conditions, including the approval of RAE Systems’ stockholders. There is no financing condition to the transaction.

“Over the years, we have built a strong reputation in the safety industry, a quality, diverse product and technology portfolio, and a dedicated, result-oriented employee base, all of which are contemplated in this transaction,” said Robert Chen, RAE Systems president and chief executive officer. “After an extensive review of our strategic alternatives, the special committee of our board of directors has determined that this transaction provides for the best value to our stockholders. RAE Systems has successfully navigated through a great deal of change over the past few years. With this newest evolution, RAE Systems will leverage Battery Ventures’ strategy and vision to help increase its industry presence via organic growth and complementary acquisitions. Looking ahead, we will continue to execute on our strategy to be a leading innovator through the advancement of intelligent, connected, wireless gas and radiation detection solutions. Throughout this transaction, RAE Systems management and employees will remain committed to customer service, quality and operating excellence.”

Jesse Feldman, Battery Ventures Partner, stated, “RAE Systems has significant long-term market growth potential, and we are excited to partner with the company on driving this growth both organically and through strategic acquisitions. Our prior experience and growing interest in industrial technologies makes RAE Systems a natural investment for Battery. We are eager to support the company through its next phase of evolution and look forward to working with RAE’s talented employee base, valuable customer and partner ecosystems, and industry leading technology platform to get there.”

A special committee of the RAE Systems Board of Directors and the disinterested members of the board have unanimously approved the agreement and recommend RAE Systems’ stockholders approve the transaction.

The company will file a proxy statement with the Securities and Exchange Commission, and a shareholder meeting will be held within 60 days following the SEC’s review. Management will hold a conference call to discuss this transaction today, September 20, at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). Access instructions for the call are included later in this release.

After the completion of this transition, the RAE Systems board of directors will include Mr. Chen and Dr. Peter C. Hsi, co-founders of RAE Systems, who will also remain as stockholders in RAE Systems, as well as Mr. Feldman and Morgan Jones of Battery Ventures.

UBS Investment Bank is acting as financial advisor to the Special Committee of the Board of RAE Systems, and Fenwick & West LLP, is acting as legal advisor to the Special Committee.

Conference Call Details
The conference call will take place today, September 20, at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). The conference call will feature remarks by Robert I. Chen, chief executive officer. Mr. Chen and Randall Gausman, chief financial officer, will be available for a question-and-answer session. The call can be accessed in the U.S., toll-free, by dialing 888-656-7430 and internationally by dialing +01-913-981-5583 approximately 15 minutes prior to the start of the call. Please use pass-code: 5094348. The conference call will also be broadcast live over the Internet and available for replay for 90 days at www.raesystems.com. A replay of the call will also be available via telephone for two days, beginning two hours after the call. To listen to the telephone replay in the U.S., please dial 888-203-1112. International callers please dial +1-719-457-0820. Enter access code 5094348.

About Battery Ventures
Since 1983, Battery has been investing in technology and innovation worldwide. The firm partners with entrepreneurs and management teams across technology sectors, geographies and stages of a company’s life, from start-up and expansion financing, to growth equity and buyouts.

Battery has supported many breakthrough companies around the world, including @stake (acquired by Symantec), Airespace (acquired by Cisco), Akamai Technologies, Inc. (NASDAQ: AKAM), Bladelogic (acquired by BMC Software), Cbeyond (NASDAQ: CBEY), Healthvision (acquired by Lawson), LIFFE (acquired by Euronext), Neoteris (acquired by Netscreen), Nova Analytics (acquired by ITT) and Omniture (acquired by Adobe). Its current portfolio includes firms such as Brightree, Consona, ExactTarget, GreenBytes, HighJump Software, Nova Holdings LLC, Opscode, Rogue Wave Software and Vero Software.

Battery has a long history of technology-based private equity transactions and is adept at complex deal structures across a variety of market sectors. From offices in Boston, Silicon Valley and Israel, Battery manages $4 billion in committed capital, including its current fund of $750M. For more information, visit www.battery.com.

About RAE Systems
RAE Systems is a leading global provider of rapidly deployable connected, intelligent gas detection systems that enable real-time safety and security threat detection. RAE Systems products are used in more than 95 countries by many of the world’s leading corporations and government agencies. RAE Systems offers a full line of wirelessly enabled solutions including personal, hand-held, transportable, and fixed instruments designed to meet the needs of any usage scenario. Applications include energy production, refining, industrial and environmental safety, public venue safety and government first responder markets. For more information about RAE Systems, please visit www.raesystems.com.

Safe Harbor Statement
This press release may contain “forward-looking” statements, as that term is used in Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, without limitation: expressions of “belief,” “anticipation,” or “expectations” of management; statements as to industry trends or future results of operations of RAE Systems and its subsidiaries; and other statements that are not historical fact. These types of statements address matters that are subject to risks and uncertainties, which could cause actual results to differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the general economic and industry factors, the resolution of issues associated with the Company’s Foreign Corrupt Practices Act, investigation and receptiveness of the market to RAE Systems and its products. In addition, our forward-looking statements should be considered in the context of other risk factors discussed in our filings with the Securities and Exchange Commission, including but not limited to our annual report on Form 10-K and Form 10-Q filings, available online at http://www.sec.gov. All forward-looking statements are based on information available to the company on the date hereof, and the company assumes no obligation to update such statements.

Additional Information About the Transaction and Where You Can Find It

In connection with the transaction, RAE Systems will file a proxy statement with the SEC for RAE Systems’ special stockholder meeting and stockholders are strongly advised to read the proxy statement when it becomes available because it will contain important information about the Merger. Investors and stockholders may obtain a free copy of the proxy statement (when available) and other documents filed by RAE Systems at the SEC’s web site at http://www.sec.gov. The proxy statement (when available) and other relevant documents may also be obtained for free from RAE Systems by directing a request to RAE Systems, Inc., c/o Investor Relations, 3775 North First Street, San Jose, California 95134, telephone: 408-952-8200.

RAE Systems and its directors, executive officers and certain other members of its management and employees may be deemed to be participants in the solicitation of proxies from its stockholders in connection with the proposed transaction. Certain information regarding the interests of such directors and executive officers is included in RAE Systems’ Proxy Statement for its 2010 Annual Meeting of Stockholders filed with the SEC on April 23, 2010, and information concerning all of the participants in the solicitation will be included in the proxy statement relating to the proposed transaction when it becomes available. Each of these documents is, or will be, available free of charge at the SEC’s website at http://www.sec.gov and from RAE Systems, Inc., c/o Investor Relations, 3775 North First Street, San Jose, California 95134, telephone: 408-952-8200.

IR Contact:
Becky Herrick
Lippert/Heilshorn & Associates, Inc
ph: 415-433-3777
bherrick@lhai.com

Amy Grady
Battery Ventures
ph: 650-372-3939
agrady@battery.com

Arrow Electronics, Inc. to Acquire Nu Horizons Electronics Corp. (NUHC) in an All-Cash Transaction

Sep. 20, 2010 (Business Wire) — Nu Horizons Electronics Corp. (Nasdaq: NUHC; “Nu Horizons”) today announced the signing of a definitive agreement providing for the acquisition of Nu Horizons by Arrow Electronics, Inc. (NYSE: ARW; “Arrow”) in an all-cash transaction in which Nu Horizons shareholders will receive $7.00 for each share of Nu Horizons common stock they own.

Nu Horizons is a leading global distributor of advanced technology semiconductor, display, illumination and power solutions to a wide variety of commercial original equipment manufacturers and electronic manufacturing services providers.

“This transaction represents an excellent value for Nu Horizons’ shareholders and a compelling opportunity for our employees, customers and suppliers,” stated Martin Kent, CEO and President of Nu Horizons. “To compete successfully in today’s global marketplace, size and scale are very important. We are pleased to become part of a leading global company with enhanced resources. Arrow’s world-class operational capabilities and supply chain will enable Nu Horizons to continue to deliver industry-leading value to our customers.”

Under the terms of the agreement, which has been approved by both boards of directors, Nu Horizons shareholders will receive $7.00 per share in cash for Nu Horizons common stock. This represents a significant premium for Nu Horizons shareholders based on the closing stock price of Nu Horizons on September 17, 2010. The transaction is subject to the approval of shareholders of Nu Horizons as well as customary closing conditions and regulatory approvals. The companies expect the transaction to close in the fourth quarter of 2010.

Houlihan Lokey acted as exclusive financial advisor and Farrell Fritz, P.C. LLP acted as legal counsel to Nu Horizons.

About Nu Horizons

Nu Horizons is a leading global distributor of advanced technology semiconductor, display, illumination and power solutions to a wide variety of commercial original equipment manufacturers (OEMs) and electronic manufacturing services providers (EMS). With sales facilities in 54 locations across North America, Europe and Asia and regional logistics centers throughout the globe, Nu Horizons partners with a limited number of best-in-class suppliers to provide in-depth product development, custom logistics and life-cycle support to its customers. Information on Nu Horizons and its services is available at www.nuhorizons.com.

Forward Looking Statement

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements related to the benefits of the proposed transaction between Arrow Electronics, Inc. (“Arrow”) and Nu Horizons Electronics Corp. (“Nu Horizons”). These forward-looking statements are based on information available to Arrow and Nu Horizons as of the date of this release and current expectations, forecasts and assumptions and involve a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks and uncertainties include a variety of factors, some of which are beyond Arrow’s or Nu Horizons’ control. In particular, such risks and uncertainties include: the risk that the transaction does not close, including the risk that the requisite stockholder and regulatory approvals may not be obtained; the level of business and consumer spending for electronic products; the competitive environment within the electronics industry; the ability of the Company to expand its operations; the financial strength of the Company’s customers and suppliers; the cyclical nature of the distributor industry; pricing and gross margin pressures; loss of key customers; the ability to control of costs and expenses; the threat or occurrence of international armed conflict and terrorist activities both in the United States and internationally; risks and costs associated with increased and new regulation of corporate governance and disclosure standards (including pursuant to Section 404 of the Sarbanes-Oxley Act of 2002); and risks involving governmental regulation. Information concerning additional factors that could cause results to differ materially from those projected in the forward-looking statements is contained in Arrow’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on February 3, 2010, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other of Arrow’s SEC filings, and Nu Horizons’ Annual Report on Form 10-K as filed with the SEC on May 7, 2010, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other of Nu Horizons SEC filings. These forward-looking statements should not be relied upon as representing Arrow’s or Nu Horizons’ views as of any subsequent date and neither undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made.

Augusta (AZC) Announces Minority JV with Korean Consortium

VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 09/16/10 — Augusta Resource Corporation (TSX: AZC)(NYSE Amex: AZC) (“Augusta” or “the Company”) announces that its wholly-owned subsidiary, Rosemont Copper Company (“Rosemont”), today entered into an Earn-In Agreement with a Korean consortium, the members of which are Korea Resources Corporation (“KORES”) and LG International Corp. (“LGI”) (together “KORES/LGI”), whereby KORES/LGI shall acquire a 20% joint venture interest in the Rosemont copper molybdenum project in Pima County, Arizona in consideration for funding US$176,000,000 (the “Investment”) of the project expenses. US$70,000,000 will be advanced to fund development pre-permitting and US$106,000,000 will be advanced to fund construction. As funds for the Investment are advanced, KORES/LGI will earn their proportionate interest in the joint venture.

Pursuant to the Earn-In Agreement, KORES/LGI and Rosemont have entered into a Joint Venture Agreement governing their relationship. KORES/LGI and Rosemont have also agreed to enter into an off-take agreement on market terms in respect of 30% of copper concentrate and 20% of copper cathode and molybdenum concentrates annually produced by the Rosemont project.

Augusta’s President and CEO Gil Clausen said: “The US$176 million equity investment by KORES and LGI, together with the US$230 million in funding previously committed by Silver Wheaton and combined with Augusta’s contributions to date will provide about 50% of the total project funding. We are well advanced in discussions with project finance lenders for the balance of the funding. The steps taken today have substantially de-risked the project and will enable timely project construction upon receipt of final permits.”

About Korea Resources Corporation

Korea Resources Corporation is wholly-owned by the Korean government and is charged with a policy mandate to further Korea’s access to strategically important mineral resources, both domestically and internationally. The company carries out the Korean government’s mineral resources policy objectives by engaging directly, or indirectly through joint ventures or in the form of minority investments, in overseas exploration, development and production of strategically important mineral resources, and managing the nation’s stockpile of rare mineral resources.

About LG International Corp.

LG International Corp (LGI) specializes in commodity investments, industrial products, information technology products, and consumer goods. The company is the trading arm of LG Group, one of the largest conglomerates of South Korea. LGI operates in Asia and Europe.

About Augusta

Augusta is a base metals company focused on advancing the Rosemont copper deposit near Tucson, Arizona. Rosemont hosts a large copper/molybdenum reserve that may account for about 10% of US copper output once in production in 2012 (for details refer to www.augustaresource.com). The exceptional experience and strength of Augusta’s management team, combined with the developed infrastructure and robust economics of the Rosemont project, will propel Augusta to become a solid mid-tier copper producer. The Company is traded on the Toronto Stock Exchange and the NYSE Amex under the symbol AZC, and on the Frankfurt Stock Exchange under the symbol A5R.

For additional information please visit www.augustaresource.com.

CAUTIONARY STATEMENTS REGARDING FORWARD LOOKING INFORMATION

Certain of the statements made and information contained herein may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and forward-looking information within the meaning of applicable Canadian securities laws. Such forward-looking statements and forward-looking information include, but are not limited to statements concerning: the Company’s plans at the Rosemont Project; estimated production; and capital and operating and cash flow estimates. Forward-looking statements or information include statements regarding the expectations and beliefs of management. Often, but not always, forward-looking statements and forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information include, but are not limited to, statements or information with respect to known or unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information.

Forward-looking statements or information are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements or information, including, without limitation, risks and uncertainties relating to: history of losses; requirements for additional capital; dilution; loss of its material properties; interest rates increase; global economy; no history of production; speculative nature of exploration activities; periodic interruptions to exploration, development and mining activities; environmental hazards and liability; industrial accidents; failure of processing and mining equipment; labour disputes; supply problems; commodity price fluctuations; uncertainty of production and cost estimates; the interpretation of drill results and the estimation of mineral resources and reserves; legal and regulatory proceedings and community actions; title matters; regulatory restrictions; permitting and licensing; volatility of the market price of Common Shares; insurance; competition; hedging activities; currency fluctuations; loss of key employees; as well as those factors discussed in the section entitled “Risk Factors” in the Company’s Annual Information Form dated March 25, 2010. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. The Company disclaims any intent or obligation to update forward-looking statements or information except as required by law, and you are referred to the full discussion of the Company’s business contained in the Company’s reports filed with the securities regulatory authorities in Canada and the United States.

Contacts:
Augusta Resource Corporation
Meghan Brown
Investor Relations Manager
(604) 638 2002
mbrown@augustaresource.com
www.augustaresource.com

China MediaExpress (CCME) Announces Share Repurchase Program

Sep. 16, 2010 (Business Wire) — China MediaExpress Holdings, Inc. (NASDAQ GS: CCME) (“CME” or “Company”), China’s largest television advertising operator on inter-city and airport express buses, today announced that its Board of Directors has approved a share repurchase program for up to $30 million of its common stock. The share repurchase authorization is effective immediately and remains in effect for one year.

Under the terms of the stock repurchase plan, the Company may repurchase shares from time to time through a combination of open market repurchases, privately negotiated transactions and accelerated share repurchase transactions in compliance with applicable securities laws and regulations including the SEC’s Rules 10b5-1 and 10b-18. The timing and number of shares repurchased will depend on a variety of factors, including the $30 million maximum, the stock price, and availability and market conditions. The Company may suspend or discontinue the stock repurchase program at any time. The repurchase program will be funded using the Company’s available cash. As of August 31, 2010, there were approximately 34.3 million shares of CME common stock outstanding.

Mr. Zheng Cheng, CME’s Chairman and Chief Executive Officer, noted, “CME has a strong balance sheet. Our Board of Directors believes that the current share price of our common stock does not reflect the Company’s fair value. The share repurchase program represents a good use of a portion of our cash position, is an attractive investment opportunity for CME and its shareholders and is consistent with our commitment to enhance stockholder value.”

CME, through contractual arrangements with Fujian Fenzhong, an entity majority owned by CME’s former majority shareholder, operates the largest television advertising network on inter-city and airport express buses in China. While CME has no direct equity ownership in Fujian Fenzhong, through the contractual agreements CME receives the economic benefits of Fujian Fenzhong’s operations. Fujian Fenzhong generates revenue by selling advertisements on its network of television displays installed on over 23,400 express buses originating in seventeen of China’s most prosperous regions, including the four municipalities of Beijing, Shanghai, Tianjin and Chongqing and thirteen economically prosperous regions, namely Guangdong, Jiangsu, Jiangxi, Fujian, Sichuan, Hebei, Anhui, Hubei, Shandong, Shanxi, Inner Mongolia, Zhejiang and Hunan.

CME is included in the Russell Global Index. For more information visit: www.ccme.tv.

Fuwei (FFHL) Films Reports Strong Sales in BOPET Films

BEIJING — (Marketwire) — 09/16/10 — Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) (“Fuwei Films” or the “Company”), a manufacturer and distributor of high-quality BOPET plastic films in China, today reported a strong upturn in the sale of BOPET films during the third quarter of 2010.

The overall Chinese BOPET film industry is growing rapidly. In July and August the average sales price of Fuwei Films has increased over 10% compared with the first half of this year. Certain products have seen price increases of over 20% compared to the first six months of 2010. According to industry estimates in China, prices may continue to rise significantly in the next a few months.

Due to high demand, Fuwei Films is at high production levels for its products. Due to improved market conditions, the company expects the financial results of the second half of 2010 to be increased compared with the first six months of the year.

“Since the second quarter, the demand for BOPET films has been increasing, particularly coming from overseas customers,” said Mr. Xiaoan He, Chairman and CEO of Fuwei. “We believe this presents a great opportunity to improve Fuwei’s performance by allowing us to develop our business in general and realize better earnings in the third quarter.”

About Fuwei Films

Fuwei Films conducts its business through its wholly owned subsidiary, Fuwei Films (Shandong) Co., Ltd. (“Fuwei Shandong”). Fuwei Shandong develops, manufactures and distributes high-quality plastic films using the biaxial oriented stretch technique, otherwise known as BOPET film (biaxially oriented polyethylene terephthalate). Fuwei Films’ BOPET film is widely used to package food, medicine, cosmetics, tobacco, and alcohol, as well as in the imaging, electronics, and magnetic products industries.

Safe Harbor

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are subject to risks. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission which, among other things, include both the short and long-term effects of the global financial crisis on the Company and the BOPET film industry; competition in the BOPET film industry; growth of, and risks inherent in, the BOPET film industry in China; uncertainty as to future profitability and our ability to obtain adequate financing for our planned capital expenditure requirements; uncertainty as to our ability to continuously develop new BOPET film products and keep up with changes in BOPET film technology; risks associated with possible defects and errors in our products; uncertainty as to our ability to protect and enforce our intellectual property rights; uncertainty as to our ability to attract and retain qualified executives and personnel; and uncertainty in acquiring raw materials on time and on acceptable terms, particularly in view of the volatility in the prices of petroleum products in recent years. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release. Actual results of our operations may differ materially from information contained in the forward-looking statements as a result of the risk factors.

For more information, please contact:

In China:

Ms. Maggie Huang
Investor Relations Manager
Phone: +86-10-6852-2612
Email: fuweiIR@fuweifilms.com

In the U.S.:

Ms. Leslie Wolf-Creutzfeldt
Investor Relations
Grayling
Phone: +1-646-284-9472
Email: leslie.wolf-creutzfeldt@grayling.com

Seven Arts Pictures Inc. to Acquire Additional Shares in Seven Arts Pictures Plc (SAPX)

HOLLYWOOD, CA — (Marketwire) — 09/16/10 — Seven Arts Pictures Inc. (“SAP”), a private company controlled by Seven Arts’ CEO Peter Hoffman and a principal shareholder of Seven Arts Pictures Plc (NASDAQ: SAPX), announced today that it has agreed to continue its purchase of shares of SAPX between now and September 30, 2010, subject to market conditions. SAP’s share purchases to date will be reflected in its filing with the Securities and Exchange Commission.

Peter Hoffman comments, “I am optimistic about our prospects and the outlook for the future based on films in development, such as the recently announced ‘Neuromancer’ project, and the earnings potential of films now being released such as ‘Pool Boys’ and ‘Night of the Demons.’ SAP plans to purchase common stock on the open market in an amount up to 200,000 shares, market conditions permitting.”

About SAP:

Seven Arts Pictures Inc. (“SAP”) was founded by Peter and Susan Hoffman and is the majority shareholder in Seven Arts Pictures Plc (NASDAQ: SAPX). SAP engages in the development, acquisition, financing, production, and licensing of theatrical motion pictures for exhibition in domestic (i.e. the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.

Cautionary Information Regarding Forward-Looking Statements:
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated.

Seven Arts Pictures Inc. contact:
Peter Hoffman
+1 323-692-5000
phoffman@7artspictures.com

Calix (CALX) to Acquire Occam Networks (OCNW)

Sep. 16, 2010 (Business Wire) — In the “Conference Call” section, the U.S. Live Call Access Dial-in phone number should read: (866) 788-0543 (sted (866) 778-0543).

The corrected release reads:

CALIX TO ACQUIRE OCCAM NETWORKS

Acquisition will bring together key innovators in Ethernet, copper, and fiber access technologies, enhancing the portfolio of access systems and software available to communications service providers and enabling greater broadband services proliferation

Calix, Inc. (NYSE:CALX) and Occam Networks, Inc. (NASDAQ:OCNW) today announced that the companies have entered into a definitive agreement for Calix to acquire Occam Networks in a stock and cash transaction valued at approximately $171 million, which is approximately $7.75 per outstanding share of Occam Networks stock.

Upon the completion of the acquisition, each outstanding share of Occam Networks common stock (other than those shares with respect to which appraisal rights are available, properly exercised and not withdrawn) will be converted into the right to receive (a) $3.8337 per share in cash, without interest plus (b) 0.2925 of a validly issued, fully paid and non-assessable share of Calix common stock. After the completion of the acquisition, former Occam Networks stockholders will own between 16.5 percent and 18.9 percent of the outstanding shares of Calix’s common stock based on the number of Calix shares outstanding as of September 15, 2010.

Additionally, after the completion of the acquisition, one non-management member of the current Occam Networks Board of Directors is expected to be appointed to serve on the Calix Board of Directors.

The combined organization of Calix and Occam Networks is expected to provide communications service providers across North America, the Caribbean, Latin America, and select global markets with an enhanced portfolio of advanced broadband access systems, and accelerate innovation across the expanded Calix Unified Access portfolio. The acquisition is expected to result in more access options over both fiber and copper for communications service providers to deploy, which could expedite the proliferation of advanced broadband services to both residential and business subscribers, including such services as high-speed Internet, IPTV, VOIP, Ethernet business services, and other advanced broadband applications.

“The rate of change is accelerating for communications service providers, and Calix is fully committed to providing our customers with the broadest portfolio of innovative access network options to adapt to this changing world,” said Carl Russo, president and chief executive officer of Calix. “By combining Occam Networks’ expertise in IP and Ethernet, Calix’s strength in fiber access, and both companies’ experience in copper access, we believe there is a clear opportunity to further enhance the Calix Unified Access portfolio, accelerate its future innovation, and enable greater broadband deployment by communications service providers globally. As a result of this acquisition, communications service providers can expect new innovations to the expanded Calix Unified Access portfolio that directly address the emerging needs of the broadband-connected consumer while also making these communications service providers more capitally and operationally efficient. We are excited about what this combination of top engineering and support talent will mean to bringing new and accelerated access network innovation to our joint customers and communications service providers.”

“With more than 380 communications service providers as customers and a robust access systems portfolio, Occam Networks has become synonymous with IP and Ethernet access innovation, yet with the rate of change in our industry continuing to increase, we were looking for ways to accelerate our rate of innovation,” said Bob Howard-Anderson, Occam Networks’ president and chief executive officer. “By combining our extensive IP and Ethernet access platforms and resources with Calix’s robust Unified Access portfolio and deep expertise in fiber access, we lay a foundation for extensive future innovation. We are excited about the opportunity to combine forces with Calix, and with the cultures of continued innovation and commitment to customer success that both companies share, we believe we can bring accelerated access network innovation and opportunity to communications service providers, consumers, and businesses alike.”

Calix expects to complete the acquisition in the fourth quarter of 2010 or first quarter of 2011, subject to Occam Networks stockholder approval, receipt of required regulatory clearance and the satisfaction of certain other customary closing conditions. Occam Networks stockholders representing approximately 27 percent of Occam Networks’ outstanding common stock have signed an agreement to vote their shares in favor of this transaction. It is anticipated that the acquisition will be accretive to Calix’s non-GAAP earnings per share in the second quarter of 2011.

Conference Call

In conjunction with this announcement, Calix and Occam Networks will host a joint conference call to discuss the proposed acquisition at 5:30 a.m. PDT (8:30 a.m. EDT) today. A live audio webcast and replay of the call will be available in the Investor Relations section of the Calix web site at http://investor-relations.calix.com.

Live call access information:

• Dial-in number: (866) 788-0543 (U.S.) or (857) 350-1681 (outside the U.S.)
• Passcode: 46029329

Replay call access information:

• Replay call dial-in: (888) 286-8010 (U.S.) or (617) 801-6888 (outside the U.S.)
• Passcode: 46383469

The conference call and webcast will include forward looking information.

About Calix

Calix, Inc. (NYSE: CALX) is a leading provider in North and Latin America of broadband communications access systems and software for copper- and fiber- based network architectures that enable communications service providers to connect to their residential and business subscribers. Calix enables communications service providers to provide a wide range of revenue-generating services, from basic voice and data to advanced broadband services, over legacy and next-generation access networks. The Calix Unified Access Portfolio helps these companies to transform their legacy and mixed protocol access networks to fiber and Ethernet. Calix has shipped over seven million ports of its Unified Access Infrastructure portfolio to more than 500 North American and international customers, whose networks serve over 40 million subscriber lines in total. For more information, visit the Calix website at www.calix.com.

About Occam Networks

Occam Networks’ broadband access solutions empower service providers to offer profitable new voice, data and video services over copper and fiber. Occam systems deliver flexibility and scalability in a Triple Play world. Over three million BLC 6000 ports are currently deployed at over 380 service providers worldwide. For more information, please visit www.occamnetworks.com.

Occam Networks and Occam BLC 6000 are either registered trademarks or trademarks of Occam Networks, Inc. in the United States and/or other countries.

All other trademarks mentioned are the property of their respective owners.

Additional Information and Where You Can Find It

Calix will file a Registration Statement on Form S-4 containing a proxy statement/prospectus and other documents concerning the proposed acquisition with the Securities and Exchange Commission (the “SEC”). Investors are urged to read the proxy statement/prospectus when it becomes available and other relevant documents filed with the SEC because they will contain important information. Security holders may obtain a free copy of the proxy statement/prospectus (when it is available) and other documents filed by Calix and Occam with the SEC at the SEC’s web site at www.sec.gov. The proxy statement/prospectus and other documents may also be obtained for free by contacting Calix Investor Relations by e-mail at Carolyn.Bass@Calix.com, by telephone at 415-445-3232 or by mail at Investor Relations, Calix, Inc., 1035 N. McDowell Blvd., Petaluma, CA 94954 or by contacting Occam Investor Relations by e-mail at ir@occamnetworks.com, by telephone at 805-692-2957 or by mail at Occam Networks Investor Relations 6868 Cortona Drive, Santa Barbara, CA 93117.

Participants in the Acquisition of Occam Networks

Calix, Occam Networks, certain of their respective directors, executive officers, members of management and employees may, under the rules of the SEC, be deemed to be participants in the solicitation of proxies in favor of the proposed merger. Information regarding the persons who may be considered “participants” in the solicitation of proxies will be set forth in Calix’s proxy statement/prospectus when it is filed with the SEC. Information regarding certain of these persons and their beneficial ownership of Calix common stock as of December 31, 2009 is also set forth in the prospectus filed by Calix on March 24, 2010 with the SEC. This document is available free of charge at the SEC’s web site at www.sec.gov or by going to Calix’s Investor Relations page on its corporate website at www.calix.com. Information concerning Occam’s directors and executive officers is set forth in Occam’s proxy statement for its 2010 Annual Meeting of Stockholders, which was filed with the SEC on April 8, 2010. This document is available free of charge at the SEC’s website at www.sec.gov or by going to Occam’s Investor Relations page on its corporate web site at www.occamnetworks.com. Additional information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed merger, and a description of their direct and indirect interests in the proposed merger, which may differ from the interests of Calix stockholders or Occam stockholders generally will be set forth in the proxy statement/prospectus when it is filed with the SEC.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements can be identified by the words, “believes,” “views,” “expects,” “projects,” “hopes,” “could,” “will,” “intends,” “should,” “estimate,” “would,” “may,” “anticipates,” “plans” and other similar words. These statements are based on management’s current expectations, estimates, forecasts, projections and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The forward-looking statements contained in this document include statements about the timing of completion of the acquisition, future financial and operating results; benefits of the acquisition to stockholders, employees and customers; potential synergies and cost savings resulting from the acquisition; the ability of the combined organization to drive growth and expand their relationships, the ability of the combined organization to provide an enhanced portfolio of advanced broadband access systems, increase and accelerate access innovation, increase access options, enable greater broadband deployment by communications service providers globally and make communications service providers more capitally and operationally efficient; anticipated accretion to non-GAAP earnings; and other statements regarding the proposed acquisition. These statements are not guarantees of future performance, involve risks, uncertainties and assumptions that are difficult to predict, and are based upon assumptions as to future events that may not prove accurate. Therefore, actual outcomes and results may differ materially from what is expressed herein. For example, if Occam Networks does not receive required stockholder approval or the parties fail to satisfy other conditions to closing, the transaction may not be consummated. In any forward-looking statement in which Calix or Occam Networks expresses an expectation or belief as to future results, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement or expectation or belief will result or be achieved or accomplished. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: failure of the Occam Networks stockholders to approve the proposed transaction; the challenges and costs of closing, integrating, restructuring and achieving anticipated synergies; the ability to retain key employees; and other economic, business, competitive, and/or regulatory factors affecting the businesses of Calix and Occam Networks generally, including those set forth in the filings of Calix with the Securities and Exchange Commission, especially in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Calix’s prospectus filed with the SEC on March 24, 2010 and its quarterly reports on Form 10-Q, Occam Networks’ annual reports on Form 10-K and quarterly reports on Form 10-Q, each of Calix’s and Occam Networks’ current reports on Form 8-K and other SEC filings. These forward-looking statements speak only as of the date hereof. Calix and Occam Networks are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events, or otherwise.

Gulf Resources (GFRE) Raises Fiscal Year 2010 Guidance

SHANDONG, China, Sept. 15 /PRNewswire-Asia-FirstCall/ — Gulf Resources, Inc. (Nasdaq: GFRE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that the Company has raised its guidance for fiscal year 2010 based upon the favorable bromine pricing environment and improved production efficiency.

Due to the strong demand for bromine in China, especially from the application of the pharmaceutical sector, bromine prices have continued to rise and reached over RMB 23,000 per ton in the beginning of September 2010. Given the improved pricing environment, the Company is renegotiating contract prices with customers to incorporate the current market price, to be effective beginning in October 2010. In addition, the management conducted a restructuring of bromine factory employees in the beginning of July 2010 to improve production efficiency and continues to implement cost controls to maintain profit margins.

As a result of the increase in bromine prices, Gulf Resources has raised its 2010 full-year guidance for revenue from between $146 million and $150 million to between $151 million and $155 million, an increase of 37% to 41% over 2009 revenues of $110.3 million. The company has also raised its net income guidance from between $44 million and $46 million to between $48 million and $50 million, or between $1.38 and $1.44 per diluted share, an increase of between 57% and 63% over 2009 net income of $30.6 million. This updated guidance does not take into account the impact of any additional potential acquisitions.

“We are encouraged by the favorable pricing environment, which provides us with the confidence that we will be able to achieve strong financial performance in the second half of 2010,” said Mr. Xiaobin Liu, CEO of Gulf Resources. “We continue to see strong bromine demand in the domestic market and believe the current bromine prices are sustainable for the foreseeable future. We are optimistic about our strategy to continue to consolidate our leadership position in China.”

About Gulf Resources, Inc.

Gulf Resources, Inc. operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and Shouguang Yuxin Chemical Industry Co., Limited (“SYCI”). The Company believes that it is one of the largest producers of bromine in China. Elemental Bromine is used to manufacture a wide variety of compounds utilized in industry and agriculture. Through SYCI, the Company manufactures chemical products utilized in a variety of applications, including oil & gas field explorations and as papermaking chemical agents. For more information about the Company, please visit http://www.gulfresourcesinc.cn .

Forward-Looking Statements

Certain statements in this news release contain forward-looking information about Gulf Resources and its subsidiaries business and products within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. The actual results may differ materially depending on a number of risk factors including, but not limited to, the general economic and business conditions in the PRC, future product development and production capabilities, shipments to end customers, market acceptance of new and existing products, additional competition from existing and new competitors for bromine and other oilfield and power production chemicals, changes in technology, the ability to make future bromine asset purchases, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company’s reports filed with the Securities and Exchange Commission. Gulf Resources undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

    For more information, please contact:

    Gulf Resources, Inc.
     David Wang, VP of Finance
     Email: gfre.2008@vip.163.com

     Helen Xu
     Email: beishengrong@vip.163.com
     Web:   http://www.gulfresourcesinc.cn

    CCG Investor Relations Inc.
     Linda Salo, Sr. Financial Writer
     Phone: +1-646-922-0894
     Email: linda.salo@ccgir.com

     Crocker Coulson, President
     Phone: +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:   http://www.ccgirasia.com

Ruby Creek Resources (RBYC) Announces New Board Member

NEW YORK, NY — (Marketwire) — 09/15/10 — Ruby Creek Resources, Inc. (OTCBB: RBYC), a gold exploration and mining company with operations in Tanzania, announces that Mr. David Bukzin has joined the Board of Directors. Mr. Bukzin is a significant shareholder of Ruby Creek and has just returned from Tanzania and his first trip to the Mkuvia Gold Project.

Mr. Bukzin is the Partner-in-Charge of Marcum LLP’s SEC Practice Group. Marcum is one of the nation’s largest independent public accounting and advisory services firms. He founded and spearheads several of the Marcum’s practice areas. As the Partner-In-Charge of the SEC Practice, Broker-Dealer Services and Transaction Services groups, he assists clients with regulatory compliance issues, complex deal structures, raising capital and formulating strategic plans and alliances. In addition to working as a Certified Public Accountant, Mr. Bukzin is a specialist in the area of business valuation, especially as it applies to mergers and acquisitions, and corporate finance transactions. He received his B.B.A. from Baruch College in 1988. Mr. Bukzin maintains memberships with the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants.

Mr. Bukzin commented: “I was very impressed with the obvious progress being made toward bringing the Mkuvia Gold Project into full operation and I am pleased to join what I see as an outstanding and professional team.”

Mr. Robert Slavik, President and CEO of Ruby Creek Resources, said, “I am extremely happy that Mr. Bukzin has joined Ruby Creek’s Board of Directors. I know David will help us considerably as we grow our Ruby Creek.”

About Ruby Creek Resources, Inc.
Ruby Creek Resources, Inc. (www.rubycreekresources.com) is a gold exploration and mining company operating in Tanzania. Ruby Creek currently operates through its 70% owned company, Ruby Creek Resources (Tanzania) Limited. Ruby Creek Tanzania is the operator of the Mkuvia Gold Project, is establishing infrastructure and has commenced the permitting process in support of the full development and commencement of operations on the Project.

Forward-Looking Statements
This news release may include certain “Forward-looking statements” within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessary estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors, which may be identified, from time to time in the Company’s public announcements.

Signed
“Robert Slavik”

Robert Slavik
President, Ruby Creek Resources, Inc.

Ruby Creek Resources, Inc.
750 3rd Ave., 11th Floor
New York, NY USA 10017
6th Floor, Amani Place, Ohio St.
Dar es Salaam, Tanzania

Investor Relations Contact:
Porter, LeVay & Rose, Inc.
Michael Porter
President
212-564-4700
www.rubycreekresources.com

Ramius Commences Cash Tender Offer for Cypress Bioscience (CYPB) at $4.25 Per Share

NEW YORK, Sept. 15 /PRNewswire/ — Ramius Value and Opportunity Advisors LLC, a subsidiary of Ramius LLC (collectively, “Ramius”), today announced that it commenced a tender offer, through a wholly owned subsidiary, to acquire all of the outstanding shares of common stock of Cypress Bioscience, Inc. (“Cypress” or “the Company”) (Nasdaq: CYPB) for $4.25 per share in cash. This offer represents a 70% premium over the $2.50 closing price of Cypress’ stock on July 16, 2010, the last trading day before Ramius publicly announced its proposal to acquire the Company for $4.00 per share in cash.

Ramius Partner Managing Director Jeffrey C. Smith stated, “The Cypress Board rejected our earlier offer to negotiate an acquisition of the Company for $4.00 per share.  Given the Board’s continuing refusal to negotiate with us, we are taking our offer directly to the true owners of Cypress, the stockholders.  Clearly, stockholders are unhappy with the Cypress Board’s refusal to seriously consider our acquisition proposal, as demonstrated by the recent letters sent to the Board by RA Capital and Arcadia Capital.”

The offer is scheduled to expire at 12:00 Midnight, New York City time, on October 13, 2010, unless extended.

The offer is conditioned upon, among other things, (1) there being validly tendered in the offer and not properly withdrawn prior to the expiration date of the offer that number of shares of Cypress that, together with the shares then owned by Ramius, its affiliates and its subsidiaries (including, Ramius V&O Acquisition LLC (“Purchaser”)) would represent at least 90% of the total number of then-outstanding shares on a fully diluted basis, (2) Cypress’ Board of Directors having approved the offer and the proposed second-step merger described herein under Section 203 of the Delaware General Corporation Law (“DGCL”) or Ramius being satisfied, in its sole discretion, that Section 203 of the DGCL is inapplicable to the offer and the potential merger thereafter, (3) Cypress not having entered into or effectuated any agreement or transaction with any person or entity having the effect of impairing Purchaser’s or Ramius’ ability to acquire Cypress or otherwise diminishing the expected value to Ramius of the acquisition of Cypress, (4) Cypress having a balance of at least $80 million in cash or cash equivalents immediately prior to the consummation of the offer, (5) Ramius, or one of its affiliates, entering into a definitive agreement with RP Management, LLC, Administrator of Royalty Pharma Finance Trust, regarding financing to complete the purchase of all of the outstanding shares and (6) the expiration or termination of all waiting periods imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the regulations thereunder.

Innisfree M&A Incorporated is acting as information agent for Ramius’ offer and Olshan Grundman Frome Rosenzweig & Wolosky LLP is acting as legal counsel to Ramius.

The offer documents, including the Offer to Purchase and the Letter of Transmittal, will be filed today with the Securities and Exchange Commission (“SEC”). Cypress stockholders may obtain copies of the offer documents when they become available at www.sec.gov. Free copies of such documents can also be obtained when they become available by calling Innisfree M&A Incorporated, toll-free at (877) 717-3936 or collect at (212) 750-5833.

THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL ANY SHARES. THE SOLICITATION AND THE OFFER TO BUY CYPRESS’ COMMON STOCK IS ONLY BEING MADE PURSUANT TO AN OFFER TO PURCHASE AND RELATED MATERIALS THAT RAMIUS WILL FILE WITH THE SEC. STOCKHOLDERS SHOULD READ THESE MATERIALS CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING THE TERMS AND CONDITIONS OF THE OFFER. STOCKHOLDERS WILL BE ABLE TO OBTAIN THE OFFER TO PURCHASE AND RELATED MATERIALS WITH RESPECT TO THE TENDER OFFER FREE AT THE SEC’S WEBSITE AT WWW.SEC.GOV OR FROM RAMIUS BY CONTACTING INNISFREE M&A INCORPORATED, TOLL-FREE AT (877) 717-3936 OR COLLECT AT (212) 750-5833.

Any forward-looking statements contained in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently subject to a variety of risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, among others: the willingness of Cypress stockholders to tender their shares in the tender offer and the number and timing of shares tendered; the receipt of third party consents to the extent required for the acquisition; and satisfaction of the various closing conditions. Other important factors that could cause actual results to differ materially are included but are not limited to those listed in Cypress’ periodic reports and registration statements filed with the SEC. Ramius undertakes no obligation to update information contained in this release.

About Ramius LLC

Ramius LLC is a registered investment advisor that manages assets in a variety of alternative investment strategies. Ramius LLC is headquartered in New York with offices located in London, Luxembourg, Tokyo, Hong Kong and Munich.

Sunvalley Solar (SSOL) Awarded $3.69M Solar System Installation Contract

Revonergy (RNRG) Announces $500,000 Financing Agreement With Kodiak Capital Group, LLC

LONDON, UNITED KINGDOM — (Marketwire) — 09/15/10 — Revonergy Inc. (OTCBB: RNRG) announces that it has entered into an agreement (the “Agreement”) with Kodiak Capital Group, LLC for the purchase of up to 50,000 Series A Redeemable Preferred Shares at $10 per share.

Revonergy Inc. has confirmed that it has signed a Preferred Stock Purchase Agreement with Kodiak Capital Group, LLC. Under the terms of the agreement, Kodiak will purchase up to 50,000 shares of Revonergy’s Series A Redeemable Preferred Stock at $10 per share, in one or more tranches, for a total investment amount of up to $500,000. At closing Kodiak will receive five year warrants to purchase 3,750,000 common shares of Revonergy.

“This financing will provide us with general working capital and funding for the costs of due diligence related to prospective acquisitions, that the company has been pursuing. We are very pleased to have this relationship with Kodiak which we expect will expand beyond this initial investment” said Ravi Daswani President & CEO of Revonergy Inc.

“We are very impressed with the experience and knowledge of the Revonergy management team,” said Lawrence Almagno Jr., of Kodiak Capital Group LLC, “We are firm believers in the business model that Revonergy has developed, its focus, and also with the prospective acquisitions. Our fund is focused upon finding young companies with potential, and in particular finding them first. We are excited about our relationship and investment, and we look forward to working with Revonergy for many years.”

About Revonergy Inc.

Revonergy Inc. is engaged in the acquisition, development and operation of renewable energy power plants globally. The Company is focused on renewable energy projects that have the potential to generate long-term stable cash flows and renewable energy credits.

Additional information can be found at website: www.revonergy.com.

About Kodiak Capital Group

Kodiak Capital Group, LLC is engaged in assisting growth companies in all facets of their long-term strategy by providing capital and progressive business solutions. Kodiak manages a portfolio of investments in public and private equities. Founded in 2009, Kodiak has transacted in excess of $400 million in financing for companies across a multitude of industries, including biotechnology, business services, consumer products, defense, healthcare, Internet, manufacturing, medical devices, natural resources, oil and gas, renewable energy and wireless communications. Headquartered in New York City, Kodiak has assisted companies throughout North America, China and Australia.

Additional information can be found at website: www.kodiak-capital.com.

IMPORTANT DISCLAIMER: This news release may contain “forward-looking” statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Actual results may differ materially from the forward-looking statements in this press release. Additional risks and uncertainties are identified and described in the Company’s SEC reports. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Contacts:
Revonergy Inc.
Jason Knox
Investor Communications
UK +44 207 993 5700
jason.knox@revonergy.com

Golden Minerals (AUMN) Reports Additional High Grade Intercepts and Resource Expansion Drilling Program at El Quevar

GOLDEN, CO — (Marketwire) — 09/14/10 — Golden Minerals Company (NYSE Amex: AUMN) (TSX: AUM) (“Golden Minerals” or “the Company”) today announced additional high grade intercepts at holes drilled on the El Quevar Yaxtché deposit and nearby Mani target area. The Company has determined that additional drilling is warranted to further define the extent of the resource before completing the feasibility report. A larger resource base may support a higher production rate than initially contemplated. The El Quevar project is located in the Salta Province of Argentina.

Drilling at El Quevar continues to be focused on the Yaxtché deposit. Two of the most recent drill holes on the Yaxtché deposit for which results have been received and verified are drill hole QVD-211, which is located on the western portion of the Yaxtché deposit, and QVD-217, which is located on the eastern portion of the Yaxtché deposit. Drill hole QVD-211 returned 146 meters of 317 grams per tonne silver, which included 56 meters of 409 grams per tonne and five meters of 1,509 grams per tonne. Drill hole QVD-217 reported a two meter intercept of 970 grams per tonne silver and a two meter intercept of 489 grams per tonne silver. This drill hole is significant because it establishes high grade intercepts to the east of the central Yaxtché deposit where limited drilling has occurred, potentially extending the existing 2.4 kilometer strike length of the Yaxtché deposit.

Drilling is now underway on the west side of post mineral cover at the Yaxtché deposit in order to test the potential western extension of the deposit. If the mineralized zone is established on the west side of the post mineral cover, it could potentially extend the strike length of the Yaxtché deposit by an additional 1.6 kilometers. Results have also been received for a hole recently completed at the Mani target, which is located approximately 500 meters southwest of the Yaxtché deposit. Drill hole QVD-220 reported a five meter intercept of 515 grams per tonne silver and a two meter intercept of 411 grams per tonne silver. Drilling is now also being planned for the Carmen target, located approximately 300 meters north of the Yaxtché deposit, along with additional drilling at the Mani target.

To date there have been over 245 diamond drill holes completed at the El Quevar project, including 182 holes drilled on the Yaxtché deposit. The latest resource estimate based on a Canadian National Instrument 43-101 (“NI 43-101”) compliant technical report prepared by Micon International Limited (“Micon”) dated August 10, 2010 included the results from 168 holes drilled on the Yaxtché deposit, through July 15, 2010. The Micon resource estimate reported an indicated resource of approximately 9.0 million ounces of silver contained in approximately 0.9 million tonnes and an inferred resource of 51.5 million ounces of silver contained in 4.8 million tonnes. The resource estimate reported by Micon capped the grade at 3,000 grams per tonne of silver for the entire deposit, and also assumed a three meter minimum mining width.

The Yaxtché deposit is one of 11 targets currently identified at the El Quevar project. An initial six hole drill program was previously completed for the Quevar Norte target located approximately three kilometers north of the Yaxtché zone, with three of the six holes intersecting silver mineralization of greater than 100 grams per tonne, including Hole QND-002, which averaged 1,289 grams per tonne over an intercept of 28 meters. As part of the ongoing assessment in the district, the Company has terminated the Viejo Campo agreements (Jenna and Pamela targets). These target areas comprised approximately 3,000 hectares of the total 66,000 hectares at the El Quevar project.

Work on the El Quevar feasibility study continues. Construction of the underground decline at the Yaxtché deposit has advanced approximately 97 meters of the 225 meters required to access ore. The production-sized decline will be used to confirm the resource model and mining methods, and take bulk samples for additional metallurgical testing. Other ongoing work includes metallurgical testing and process design. The Company has commenced the additional drilling program, focused on resource expansion and currently estimated to cost up to $5 million, and has deferred completion of the final feasibility report until the additional drilling is completed. A larger resource may support a higher production rate, which would be reflected in the final feasibility report.

A drill hole location map and listing of all drill intercepts for the holes at El Quevar for which the Company has received and verified results are available at http://www.goldenminerals.com/.

Shelf Registration Statement

The Company has an effective S-3 shelf registration with the U.S. Securities and Exchange Commission (“SEC”). Based on the Company’s current public float, SEC rules limit the amount of securities that could be sold under the shelf to approximately $15 million.

Review by Qualified Person, Quality Control and Reports

Results of the Company’s drilling program have been reviewed, verified, and compiled under the direction of the Company’s Senior Vice President of Exploration, Robert Blakestad, M.Sc., P.Geo, L.P.G., a Qualified Person for the purpose of NI 43-101. Mr. Blakestad has over 35 years of mineral exploration experience, is a Professional Geoscientist registered in Nova Scotia and a Licensed Professional Geologist in the state of Washington.

Drill intercept lengths are down-hole lengths reflecting apparent widths of mineralization with true widths estimated to be from 90% to 95% of the reported down-hole lengths.

To ensure reliable sample results, Golden Minerals uses a quality assurance/quality control program that monitors the chain-of-custody of samples and includes the insertion of blanks, duplicates, and certified reference standards in each batch of samples. Core is photographed and sawn in half with one half retained in a secured facility for verification purposes. Sample preparation (crushing and pulverizing) is performed at an independent ISO 9001:2001 certified laboratory in Mendoza, Argentina. Prepared samples are direct-shipped to ISO 9001:2001 certified laboratories in Santiago, Chile or Vancouver, B.C. Pulp splits of mineralized intervals are re-assayed at certified independent referee laboratories in Chile and Canada.

About Golden Minerals

Golden Minerals is a Delaware corporation based in Golden, Colorado, primarily engaged in the advancement of its pipeline of exploration projects in Mexico and South America. The Company has a portfolio of more than 25 exploration projects, including the feasibility stage El Quevar project in the Salta Province of northwestern Argentina and advanced stage drilling projects in Mexico and Peru. The Company’s experienced management team has proven in house ability to explore, develop and operate mining projects.

Cautionary Note to U.S. Investors concerning Estimates of Indicated and Inferred Resources: This press release uses the terms “indicated resources” and “inferred resources” which are defined in, and required to be disclosed by, Canada National Instrument 43-101. We advise U.S. investors that these terms are not recognized by the United States Securities and Exchange Commission (the “SEC”). The estimation of indicated resources involves greater uncertainty as to their existence and economic feasibility than the estimation of proven and probable reserves. U.S. investors are cautioned not to assume that indicated mineral resources will be converted into reserves. The estimation of inferred resources involves far greater uncertainty as to their existence and economic viability than the estimation of other categories of resources. U.S. investors are cautioned not to assume that estimates of inferred mineral resources exist, are economically minable, or will be upgraded into measured or indicated mineral resources. Disclosure of “contained ounces” in a resource is permitted disclosure under Canadian regulations, however the SEC normally only permits issuers to report mineralization that does not constitute “reserves” by SEC standards as in place tonnage and grade without reference to unit measures. Accordingly, the information contained in this press release may not be comparable to similar information made public by U.S. companies that are not subject to NI 43-101.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including statements regarding indicated and inferred resource estimates at the El Quevar project; the exploration results and programs at the El Quevar project, including planned additional resource expansion drilling; results of exploration activities; planned exploration activities; potential extension of the Yaxtché deposit and potential for a higher production rate than initially contemplated; deferral of completion of the El Quevar feasibility study; planned feasibility work, the schedule for the construction of the underground decline at the Yaxtché deposit and completion of the planned feasibility study, and planned uses of the underground decline; effectiveness of the Company’s S-3 shelf registration statement and estimates of the amounts of securities that could be sold pursuant to the shelf registration statement. These statements are subject to risks and uncertainties, including results of exploration, including the additional planned resource expansion drilling at El Quevar, and whether the results support extensions of or an increase in the resources at the current Yaxtché deposit, a higher production rate than initially contemplated and engineering and other feasibility work on El Quevar; changes in geological, geostatistical and other interpretations of the Yaxtché deposit including the interpretations regarding the westward extension, continuity and strike length of the Yaxtché deposit, which may include changes resulting from additional drilling, exploration and feasibility work; availability of drills; unexpected variations in ore grade, types and metallurgy; whether the resources reported will be converted to reserves and whether the resources reported, including information regarding contained ounces, will be reduced as additional exploration and feasibility work is completed, including feasibility work on processing alternatives, projected recovery rates and costs including capital costs, operating costs and taxes; results of El Quevar feasibility work and uncertainties regarding whether El Quevar project feasibility will be supported; unexpected increases in costs of materials, supplies and personnel used in exploration or mining activities; fluctuations in silver and other metal prices; technical and permitting issues; changes in applicable law that might increase the cost or otherwise negatively affect the Company in advancing the El Quevar project; financial market conditions; whether the Company is able to sell securities under its shelf registration statement; reduction in the Company’s public float resulting from declines in the Company’s stock price or an increase in the amount of stock held by affiliates, and thus in the amount of securities that may be sold pursuant to the shelf registration statement; and the ability and success of the Company in raising adequate capital and implementing its plans. Golden Minerals Company assumes no obligation to update this information. Additional risks relating to Golden Minerals Company may be found in the periodic and current reports filed with the Securities Exchange Commission by Golden Minerals Company, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.

For additional information please visit http://www.goldenminerals.com/ or contact:

Golden Minerals Company
Jerry W. Danni
(303) 839-5060
Executive Vice President

Baldwin (BLD) Wins Multimillion Dollar Newspaper Project

Sep. 14, 2010 (Business Wire) — Baldwin Technology Company, Inc. (NYSE Amex: BLD), a leader in process automation technology for the global printing industry, announced today that it has received an order for the Express Newspapers Group, a large U.K. newspaper publisher, through the press manufacturer Koenig & Bauer AG (KBA) valued at over $2 million. The move by West Ferry Printers, a subsidiary of Express Newspapers Group, from the facility it has occupied for 24 years in the London Docklands to a new, not yet named site will go hand in hand with a huge investment in presses and auxiliary equipment over the next five years. The Baldwin scope of supply for this first phase of the project consists of a comprehensive process automation package including cleaning system technology, spray dampening and cooling systems. Installation of the Baldwin equipment on the four new compact high-performance KBA Commander CT press lines is planned to take place in various stages during 2011.

Peter Hultberg, Vice President—Global Marketing, Sales & Service, of Baldwin, commented, “We are delighted that Express Newspapers Group and Koenig & Bauer AG decided to equip these new presses with process automation technology from Baldwin .It is yet another project for our Company in the segment of high-end newspaper printing where the Baldwin product technology fits well with the high demands of these presses capable of running both newspapers as well as semi-commercial grade products such as magazines.”

Karl Puehringer, President and CEO of Baldwin added, “It is reassuring to have publishers and printers making investments in new technology which will enable them to meet the demands of productivity, automation, environment and low production costs as well as the high quality of newspapers in the future. It is a very positive signal regarding the future of print media.”

About Baldwin

Baldwin Technology Company, Inc. is a leading international supplier of process automation equipment and related consumables for the printing and publishing industries. Baldwin offers its customers a broad range of market-leading technologies, products and systems that enhance the quality of printed products and improve the economic and environmental efficiency of printing presses. Headquartered in Shelton, Connecticut, the Company has operations strategically located in the major print markets and distributes its products via a global sales and service infrastructure. Baldwin’s technology and products include cleaning systems, fluid management and ink control systems, web press protection systems and drying systems and related consumables. For more information, visit http://www.baldwintech.com

Information for investors, including an investment profile about Baldwin is available at www.hawkassociates.com/profile/bld.cfm. An online investor kit including BLD press releases, current price quotes, stock charts and other valuable information for investors is available at http://www.hawkassociates.com.

This release contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company’s control, which may cause actual results, performance or achievements of the Company to be materially different from those implied by the forward-looking statements. These factors include, but are not limited to, those detailed in the Company’s periodic filings with the Securities and Exchange Commission.

Baldwin Technology Company, Inc.

Investors:

Helen P. Oster, 203 402-1004

hposter@baldwintech.com

GeoGlobal Resources, Inc. (GGR) Signs Memorandum of Understanding in Colombia

CALGARY, ALBERTA — (Marketwire) — 09/14/10 — GeoGlobal Resources Inc. (GeoGlobal or the Company) (NYSE Amex: GGR) announces that a Memorandum of Understanding (MOU) has been signed with Petro Caribbean Resources Ltd. (PCR) relating to conducting oil and natural gas exploration and development activities in Colombia, subject to the execution by PCR of definitive agreements with the Colombian National Agency of Hydrocarbons (ANH).

The exploration activities are to be conducted on two onshore exploration blocks located in the Putumayo basin in southwest Colombia known as the Putumayo 6 (PUT 6) and Putumayo 7 (PUT 7) exploration blocks. The PUT 6 and PUT 7 cover an area of approximately 574 and 167 square kilometers, respectively.

Subject to the execution of a Joint Operating Agreement, GeoGlobal will be carried for a 10% participating interest in both the PUT 6 and PUT 7 exploration blocks through the minimum and additional work programs as bid in return for GeoGlobal providing to PCR technical assistance through the exploration phase.

Additionally, GeoGlobal is to have the right to acquire up to an additional 40% participating interest in each of the PUT 6 and PUT 7 exploration blocks exercisable on or before September 21, 2010 unless otherwise agreed and extended by both parties, in consideration of payment to PCR of GeoGlobal’s 40% participating interest share of all third party costs incurred, including performance bonds and guarantees, through exercise of the rights.

Jean Paul Roy, a Director and the former chief executive officer of GeoGlobal, has advised GeoGlobal that his wholly-owned company, Roy Group (Mauritius) Inc. (RGM), has agreed to guarantee the payment and performance of PCR’s obligations under the Colombian exploration and production contracts (the “Guarantee”). In consideration for giving the Guarantee, PCR has agreed that: (i) RGM is entitled for a period of two years to participate in any future equity financings of PCR; (ii) PCR will indemnify RGM against any and all costs which RGM may incur under or in connection with the Guarantee; and (iii) at the request of RGM, PCR will grant RGM a first lien over all of the assets and property of PCR as security for PCR’s obligations under the indemnity.

About GeoGlobal

GeoGlobal Resources Inc., headquartered in Calgary, Alberta, Canada, is a US publicly traded oil and gas company, which, through its subsidiaries, is engaged in the pursuit of petroleum and natural gas through exploration and development in India, Israel and Colombia. The Company has been focused on the development of high potential exploration targets in the Krishna Godavari, Cambay, Deccan Syneclise, and Rajasthan basin areas in India.

Cautionary Statement For Purposes Of The “Safe Harbor” Provisions Of The Private Securities Litigation Reform Act Of 1995

This press release contains statements which constitute forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995, including statements regarding the plans, intentions, beliefs and current expectations of GeoGlobal Resources Inc., its directors, or its officers with respect to the oil and gas exploration, development and drilling activities being conducted and intended to be conducted and the outcome of those activities on the exploration blocks in which the Company has an interest. The company updates forward-looking information related to operations, production and capital spending on a quarterly basis and updates reserves, if any, on an annual basis. The Company’s forward looking statements include, among others, its statements and estimates as to:

--  the statements herein regarding our plans and objectives relating to our
    future operations,
--  plans and objectives regarding the exploration, development and
    production activities conducted on the exploration blocks in India,
    Israel and Colombia where we have interests,
--  plans regarding drilling activities intended to be conducted through the
    ventures in which we are a participant, the success of those drilling
    activities and our ability and the ability of the ventures to complete
    any wells on the exploration blocks, to develop reserves of hydrocarbons
    in commercially marketable quantities, to establish facilities for the
    collection, distribution and marketing of hydrocarbons, to produce oil
    and natural gas in commercial quantities and to realize revenues from
    the sales of those hydrocarbons,
--  our ability to maintain compliance with the terms and conditions of our
    production sharing and other contracts, including the related work
    commitments, to obtain consents, waivers and extensions under the terms
    of these production sharing and other contracts as and when required,
    and our ability to fund those work commitments,
--  our plans and objectives to join with others or to directly seek to
    enter into or acquire interests in additional production sharing or
    other contracts in India, Israel, Colombia and elsewhere,
--  our assumptions, plans and expectations regarding our future capital
    requirements,
--  our plans and intentions to raise additional capital we require and our
    likelihood of success in that regard,
--  the costs and expenses to be incurred in conducting exploration, well
    drilling, development and production activities, our estimates as to the
    anticipated annual costs of those activities and the adequacy of our
    capital to meet our requirements for our present and anticipated levels
    of activities are all forward-looking statements.

We caution you that various risk factors accompany our forward-looking statements and are described, among other places, under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K, as well in our press releases. These risk factors could cause our operating results, financial condition and ability to fulfill our plans to differ materially from those expressed in any forward-looking statements made in this press release and could adversely affect our financial condition and our ability to pursue our business strategy and plans. If our plans fail to materialize, your investment will be in jeopardy. Among others, these risk factors include:

--  We cannot assure you that our assumptions or our business plans and
    objectives will prove to be accurate or be able to be attained.
--  We cannot assure you that the exploratory drilling to be conducted on
    the exploration blocks in which we hold an interest will result in a
    discovery of reserves of hydrocarbons or that any hydrocarbons that are
    discovered on the exploration blocks in which we have an interest will
    be in commercially recoverable quantities. In addition, the realization
    of any revenues from commercially recoverable hydrocarbons is dependent
    upon the ability to deliver, store and market any hydrocarbons that are
    discovered.
--  Our ability to realize material revenues cannot be assured. Our ability
    to successfully drill, test and complete significant numbers of
    producing wells cannot be assured.
--  We cannot assure you that we will have available to us the capital
    required to meet our plans and objectives at the times and in the
    amounts required or we will have available to us the amounts we are
    required to fund under the terms of the production sharing and other
    contracts we are a party to. We cannot assure that we will be successful
    in raising the additional capital we currently require.
--  We cannot assure you that we will be successful in joining any further
    ventures seeking to be granted production sharing or other contracts in
    India, Israel, Colombia or elsewhere or that we will be successful in
    acquiring interests in existing ventures.
--  We cannot assure you that we will obtain all required consents, waivers
    and extensions from a governmental or regulatory body in India or Israel
    as and when required to maintain compliance with production sharing or
    other contracts we have entered into, that we may not be adversely
    affected by any delays we may experience in receiving those consents,
    waivers and extensions, and that we may not incur liabilities under the
    production sharing or other contracts for our failure to maintain
    compliance with the requirements of and timely complete the related work
    programs.
--  We cannot assure you that Gujarat State Petroleum Corporation, the
    operator of the KG Offshore Block, may not be successful in its efforts
    to obtain payment from us on account of exploration costs it has
    expended on the KG Offshore Block for which it asserts we are liable or
    otherwise seek to hold us in breach of that Production Sharing Contract
    or commence arbitration proceedings against us and be successful in its
    assertion that it can terminate our contract with them or the Government
    of India.
--  We cannot assure you of our ability to meet our goals and objectives and
    the consequences to us from adverse developments in general economic or
    capital market conditions, events having international consequences, or
    military or terrorist activities could have a material adverse effect on
    us.

An investment in shares of our common stock involves a high degree of risk. Our periodic reports we file with the Securities and Exchange Commission and Canadian provincial authorities may be viewed at http://www.sec.gov and www.sedar.com.

Contacts:
GeoGlobal Resources Inc.
Paul B. Miller
President and CEO
403 777-9250

GeoGlobal Resources Inc.
Carla Boland
Investor Relations and Corporate Affairs
403 777-9250
403 777-9199 (FAX)
info@geoglobal.com
www.geoglobal.com

The Equicom Group
Dave Feick
Managing Director, Western Canada
403 218-2839
403 218-2830 (FAX)
dfeick@equicomgroup.com

OCZ Technology (OCZ) Announces Next Generation Ultra-Low and Extreme-Low Voltage DDR3 Memory Kits

SAN JOSE, Calif., Sept. 14, 2010 (GLOBE NEWSWIRE) — OCZ Technology Group, Inc. (Nasdaq:OCZ), a leading provider of high-performance solid-state drives (SSDs) and memory modules for computing devices and systems, unveils new Ultra-Low Voltage (ULV) and Extreme-Low Voltage (ELV) high-speed DDR3 desktop memory, providing the optimal balance of performance and power efficiency in one solution. Committed to staying ahead of the curve, OCZ is offering enthusiast-grade memory that complies with the latest JEDEC “DDR3L” low-voltage standards which ensures that system RAM runs cooler and more efficiently during intensive multi-tasking, gaming, and productivity applications.

“We are pleased to announce a complete range of low-voltage memory offerings designed for the latest crop of energy efficient platforms,” said Eugene Chang, Vice President of Product Management. “In the past, lower voltage meant lower performance, but now with our extreme-low voltage optimized memory, consumers don’t have to sacrifice high performance to also achieve energy savings.”

Developed for next generation platforms, OCZ Platinum ELV solutions run at only 1.35 volts and are the choice counterparts for leading-edge performance and reliability, meeting the demand for high-speed memory to function farther below the upper voltage threshold of Intel® Core™ i3, i5, and i7 processors. With an ideal combination of speed and latency, OCZ Platinum ELV 6GB and 4GB memory kits are specifically designed and qualified on a range of motherboards supporting this low voltage feature.

In addition to ELV solutions, OCZ’s new Reaper HPC (Heat Pipe Conduit) and Gold ULV memory operate at 1.5 volts for power savings over the maximum recommendation of 1.65V for the latest enthusiast and mainstream Intel platforms. Furthermore, Reaper and Gold ULV kits are available in high-density 12GB and 8GB configurations, supporting the latest memory-hungry applications and games with superior performance and maximum productivity, all while helping to maintain a cooler case environment.

OCZ DDR3 ELV and ULV triple-channel and dual-channel memory kits are available in PC3-12800 (1600MHz) and PC3-10666 (1333MHz) speed ratings, are 100% hand-tested for quality assurance, and feature propriety XTC (Xtreme Thermal Convection) and Reaper HPC heatspreaders for more effective heat dissipation. Furthermore, each OCZ module is backed by the OCZ Lifetime Warranty and industry-leading technical support for unparalleled peace of mind.

About OCZ Technology Group, Inc.

Founded in 2002, San Jose, CA-based OCZ Technology Group, Inc. (“OCZ”), is a leader in the design, manufacturing, and distribution of high performance and reliable Solid State Drives (SSDs) and premium computer components. OCZ has built on its expertise in high-speed memory to become a leader in the SSD market, a technology that competes with traditional rotating magnetic hard disk drives (HDDs). SSDs are faster, more reliable, generate less heat and use significantly less power than the HDDs used in the majority of computers today. In addition to SSD technology, OCZ also offers high performance components for computing devices and systems, including enterprise-class power management products as well as leading-edge computer gaming solutions. For more information, please visit: www.ocztechnology.com.

The OCZ Technology Group, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7439

Forward-Looking Statements

Certain statements in this release relate to future events and expectations and as such constitute forward-looking statements involving known and unknown factors that may cause actual results of OCZ Technology Group, Inc. to be different from those expressed or implied in the forward-looking statements. In this context, words such as “will,” “would,” “expect,” “anticipate,” “should” or other similar words and phrases often identify forward-looking statements made on behalf of OCZ. It is important to note that actual results of OCZ may differ materially from those described or implied in such forward-looking statements based on a number of factors and uncertainties, including, but not limited to, market acceptance of OCZ’s products and OCZ’s ability to continually develop enhanced products; adverse changes both in the general macro-economic environment as well as in the industries OCZ serves, including computer manufacturing, traditional and online retailers, information storage, internet search and content providers and computer system integrators; OCZ’s ability to efficiently manage material and inventory, including integrated circuit chip costs and freight costs; and OCZ’s ability to generate cash from operations, secure external funding for its operations and manage its liquidity needs. Other general economic, business and financing conditions and factors are described in more detail in “Item 1A – Risk Factors” in Part II in OCZ’s Annual Report on Form 10-K filed with the SEC on May 20, 2010. The filing is available both at www.sec.gov as well as via OCZ’s website at www.ocztechnology.com. OCZ does not undertake to update its forward-looking statements.

CONTACT:  OCZ Technology Group, Inc.
          Ryan M. Petersen, CEO
          408-733-8400

          The Investor Relations Group
          Investor Relations:
          Adam Holdsworth
          Public Relations:
          Mike Graff
          212-825-3210

Toshiba Selects AudioCodes (AUDC) Media Gateways to Enhance Network Reliability and Messaging

IRVINE, CA and LOD, ISRAEL — (Marketwire) — 09/14/10 — AudioCodes (NASDAQ: AUDC), a leading provider of Voice over IP (VoIP) technologies and Voice Network products, today announced that Toshiba America Information Systems Inc., Telecommunication Systems Division (Toshiba — www.telecom.toshiba.com) has entered into a reseller agreement to resell AudioCodes Mediant 1000 and MediaPack series media gateways for use with Toshiba’s family of Strata® CIX™ IP business telephone systems and Strata Messaging unified messaging systems.

AudioCodes media gateways provide PSTN circuit trunk-side connectivity to Strata CIX systems, converting the PSTN PRI or Analog circuits to SIP in a redundant and load-sharing architecture. Using call routing rules, the AudioCodes media gateways can detect network and equipment failures, redirecting call traffic to one or more still-active and operating Strata CIX systems, enhancing reliability and survivability.

In addition, AudioCodes media gateways can convert T.30 fax calls from the PSTN and on-site fax machines to the industry-standard T.38 fax-over-IP protocol and interfacing to Strata Messaging systems. The T.38 fax-over-IP protocol is highly reliable and improves the efficiency of unified messaging systems.

“Survivability and reliability are key concerns for companies in a wide variety of vertical markets, including public safety, utilities, health care, banking and other critical services,” said Ericson Abing, product manager for Toshiba America Information Systems Inc., Telecommunication Systems Division. “Offering AudioCodes media gateways in a redundant and load-sharing configuration automatically detects failures and redirects traffic to still-operating Strata CIX systems with no interruption in service.”

“Being selected by Toshiba for the difficult task of creating high-reliability communications solutions is a testament to the product reliability and embedded call routing intelligence within the AudioCodes media gateway products,” said Lior Aldema, chief operating officer for AudioCodes. “This relationship also demonstrates the value of the embedded T.38 fax-over-IP protocol in AudioCodes media gateways, allowing Toshiba to concentrate its development efforts on the Strata Messaging application and avoid protracted protocol development and testing.”

“We are pleased to announce our relationship with AudioCodes,” said Brian Metherell, VP and general manager of Toshiba America Information Systems Inc., Telecommunication Systems Division. “Combined with the exceptionally dependable Toshiba Strata CIX family of IP business telephone systems, AudioCodes’ products give our customers enhanced survivability and reliability.”

The Mediant 1000 Modular Media Gateway is a compact and cost-effective media gateway solution that has been designed to interface between TDM and IP networks in enterprises or small-scale carrier locations. The compact Mediant 1000 modular gateway is extremely scalable and supports multiples of one, two or four E1/T1/J1 spans or one to 24 analog ports in various FXS/FXO configurations. The Mediant 1000 also supports mixed digital/analog configurations.

The MediaPack Series Analog VoIP Gateways are cost-effective, best-of-breed technology products. These stand-alone analog VoIP Gateways provide superior voice technology for connecting legacy telephones, fax machines and PBX systems with IP-based telephony networks, as well as for integration with new IP-based PBX systems.

For more information on AudioCodes media gateways, visit: www.audiocodes.com/CPE

About AudioCodes

AudioCodes Ltd. (NASDAQ: AUDC) designs, develops and sells advanced Voice over IP (VoIP) and converged VoIP and Data networking products and applications to Service Providers and Enterprises. AudioCodes is a VoIP technology market leader focused on converged VoIP & data communications and its products are deployed globally in Broadband, Mobile, Cable, and Enterprise networks. The company provides a range of innovative, cost-effective products including Media Gateways, Multi-Service Business Gateways, Session Border Controllers (SBC), Residential Gateways, IP Phones, Media Servers and Value Added Applications. AudioCodes’ underlying technology, VoIPerfectHD™, relies on AudioCodes’ leadership in DSP, voice coding and voice processing technologies. AudioCodes High Definition (HD) VoIP technologies and products provide enhanced intelligibility and a better end user communication experience in Voice communications. For more information on AudioCodes, visit http://www.audiocodes.com

About Toshiba America Information Systems Inc. (TAIS)

Headquartered in Irvine, Calif., TAIS is comprised of four business units: Digital Products Division, Imaging Systems Division, Storage Device Division, and Telecommunication Systems Division. Together, these divisions provide mobile products and solutions, including industry-leading portable computers; televisions, TV/DVD Combination products, Blu-ray Disc and DVD products, and portable devices; imaging products for the security, medical and manufacturing markets; storage products for automotive, computer and consumer electronics applications; and IP business telephone systems with unified communications, collaboration and mobility applications. TAIS provides sales, marketing and services for its wide range of products in the United States and Latin America.

TAIS is an independent operating company owned by Toshiba America, Inc., a subsidiary of Toshiba Corporation. Toshiba is a world leader and innovator in pioneering high technology, a diversified manufacturer and marketer of advanced electronic and electrical products spanning information & communications systems; digital consumer products; electronic devices and components; power systems, including nuclear energy; industrial and social infrastructure systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 740 companies, with 204,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$68 billion). For more information on Toshiba’s leading innovations, visit the company’s Web site at www.toshiba.com.

Statements concerning AudioCodes’ business outlook or future economic performance; product introductions and plans and objectives related thereto; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements” as that term is defined under U.S. Federal securities laws. Forward-looking statements are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. These risks, uncertainties and factors include, but are not limited to: the effect of global economic conditions in general and conditions in AudioCodes’ industry and target markets in particular; shifts in supply and demand; market acceptance of new products and continuing products’ demand; the impact of competitive products and pricing on AudioCodes’ and its customers’ products and markets; timely product and technology development/upgrades and the ability to manage changes in market conditions as needed; possible disruptions from acquisitions; the integration of acquired companies’ products and operations into AudioCodes’ business; and other factors detailed in AudioCodes’ filings with the Securities and Exchange Commission. AudioCodes assumes no obligation to update the information in this release.

© 2010 AudioCodes Ltd. All rights reserved. AudioCodes, AC, AudioCoded, Ardito, CTI2, CTI², CTI Squared, HD VoIP, HD VoIP Sounds Better, InTouch, IPmedia, Mediant, MediaPack, NetCoder, Netrake, Nuera, Open Solutions Network, OSN, Stretto, TrunkPack, VMAS, VoicePacketizer, VoIPerfect, VoIPerfectHD, What’s Inside Matters, Your Gateway To VoIP and 3GX are trademarks or registered trademarks of AudioCodes Limited. All other products or trademarks are property of their respective owners. Product specifications are subject to change without notice.

© 2010 Toshiba America Information Systems Inc. All rights reserved. All product, service and company names are trademarks, registered trademarks or service marks of their respective owners. Information including, without limitation, product prices, specifications, availability, content of services, and contact information is subject to change without notice.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Toshiba PR Contact:
Teri Sawyer
T&Co.
714-536-8407
Email Contact

AudioCodes PR Contact:
Shirley Nakar
AudioCodes
+972-3-976-4000
Email Contact

Cyclacel Pharmaceuticals (CYCC) Reaches Agreement With FDA on a Special Protocol Assessment

BERKELEY HEIGHTS, N.J., Sep 13, 2010 (GlobeNewswire via COMTEX) — Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a pivotal Phase 3 trial for the Company’s sapacitabine oral capsules as a front-line treatment in elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.

“The SPA agreement with FDA represents an important milestone for Cyclacel and provides a clear registration pathway for sapacitabine,” said Spiro Rombotis, President and Chief Executive Officer of Cyclacel. “If it reaches the market, sapacitabine would be the first orally-administered drug to be offered to this patient population with the potential to serve as induction, consolidation and maintenance treatment of this life-threatening disease. In addition to progressing to Phase 3 in AML, we look forward to reporting sapacitabine Phase 2 data in myelodysplastic syndromes (MDS) and non-small cell lung cancer (NSCLC).”

The Phase 3, registration-directed, clinical trial of sapacitabine oral capsules to be conducted under the SPA will be a randomized study against an active control drug with the primary objective of demonstrating an improvement in overall survival. Sapacitabine will be administered as an outpatient treatment. Cyclacel plans to begin patient enrollment in this Phase 3 trial before the end of 2010. Additional information on the design of the trial will be provided after initiation of the study.

“We are pleased to receive the SPA Agreement letter from the FDA stating that the design and planned analysis of the pivotal Phase 3 study adequately address the objectives necessary to support the submission of a New Drug Application (NDA),” said Judy Chiao, M.D., Vice President of Clinical Development and Regulatory Affairs of Cyclacel. “AML in the elderly is a life-threatening disease with high unmet medical need. Patients with AML aged 70 years or older have a poor prognosis as the majority of these patients are not candidates for intensive induction chemotherapy because of poor tolerability to such therapy and a high risk of relapse because of the lack of effective consolidation and maintenance therapy. We will now concentrate our efforts on initiating the Phase 3 study in AML in collaboration with our clinical investigators.”

In addition to the Cyclacel-sponsored trials of sapacitabine, the company has been approached by cooperative groups seeking to conduct, largely at their expense, investigator-initiated studies of sapacitabine with alternative study designs.

About Acute Myeloid Leukemia (AML)

AML is a cancer of the blood cells that progresses rapidly and if not treated, could be fatal in a few months. AML is generally a disease of older people and is uncommon before the age of 40. The average age of a patient with AML is about 67 years. There are more than 12,300 new cases of AML, of which about half are elderly, and nearly 9,000 deaths caused by this cancer each year in the United States. A recently published review of The University of Texas M. D. Anderson Cancer Center’s historical experience with front-line intensive induction chemotherapy for elderly AML patients aged 70 years or older demonstrated that while 45% of patients achieved a complete remission, median overall survival was only 4.6 months and 36% of patients died within the first 8 weeks of treatment, underscoring the unmet need in this patient setting. &dagger;

About Special Protocol Assessment (SPA)

A Special Protocol Assessment is a binding written agreement with the FDA that the sponsor’s proposed trial protocol design, clinical endpoints and statistical analyses are acceptable to support regulatory approval. Final marketing approval depends on efficacy results, adverse event profile and an evaluation of the benefit/risk of a treatment as demonstrated in the trial. For further information regarding the SPA process, please visit the FDA website, www.fda.gov.

About sapacitabine

Sapacitabine (CYC682), an orally-available nucleoside analogue, is currently being evaluated in Phase 2 trials in patients with hematological malignancies and solid tumors. Sapacitabine acts through a dual mechanism, interfering with DNA synthesis by causing single-strand DNA breaks and inducing arrest of cell cycle progression mainly at G2-Phase. Both sapacitabine and CNDAC, its major metabolite, have demonstrated potent anti-tumor activity in preclinical studies. Over 200 patients have received sapacitabine in Phase 2 studies in AML, MDS, cutaneous T cell lymphoma (CTCL) and non-small cell lung cancer (NSCLC). Sapacitabine has been administered to approximately 170 patients in five Phase 1 studies with both hematologic malignancies and solid tumors. In December 2009 at the 51st Annual Meeting of the American Society of Hematology (ASH), Cyclacel reported data from a randomized Phase 2 study including promising 1-year survival in elderly patients with AML aged 70 years or older. Sapacitabine is part of Cyclacel’s pipeline of small molecule drugs designed to target and stop uncontrolled cell division.

About Cyclacel Pharmaceuticals, Inc.

Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Three product candidates are in clinical development: Sapacitabine (CYC682), a cell cycle modulating nucleoside analog, completed Phase 2 studies for the treatment of acute myeloid leukemia in the elderly and is in Phase 2 for myelodysplastic syndromes and lung cancer. Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and in a Phase 1 trial in combination with sapacitabine. CYC116, an Aurora kinase and VEGFR2 inhibitor, is in a Phase 1 trial in patients with solid tumors. Cyclacel’s ALIGN Pharmaceuticals subsidiary markets directly in the U.S. Xclair(R) Cream for radiation dermatitis, Numoisyn(R) Liquid and Numoisyn(R) Lozenges for xerostomia. Cyclacel’s strategy is to build a diversified biopharmaceutical business focused in hematology and oncology based on a portfolio of commercial products and a development pipeline of novel drug candidates. For additional information please visit www.cyclacel.com.

Forward-looking Statements

This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the efficacy, safety, and intended utilization of Cyclacel’s product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research and clinical trials and plans regarding partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risk that Cyclacel will not obtain approval to market its products, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words “may,” “will,” “would,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plans,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and current filings that have been filed with the Securities and Exchange Commission and are available at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

&dagger; Blood First Edition Paper, prepublished online July 28, 2010; DOI 10.1182/blood-2010-03-276485 (http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2010-03-276485v1).

(C) Copyright 2010 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel(R) are trademarks of Cyclacel Pharmaceuticals, Inc. Numoisyn(R) and Xclair(R) are trademarks of Sinclair Pharma plc.

This news release was distributed by GlobeNewswire, www.globenewswire.com

XenoPort (XNPT)) Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity

SANTA CLARA, Calif., Sep 13, 2010 (BUSINESS WIRE) — XenoPort, Inc. /quotes/comstock/15*!xnpt/quotes/nls/xnpt (XNPT 7.55, +1.35, +21.77%) announced today that it plans to move arbaclofen placarbil (AP), also known as XP19986, into Phase 3 development as a potential treatment of spasticity in multiple sclerosis (MS) patients. Following discussions with the U.S. Food and Drug Administration (FDA), XenoPort intends to conduct a single placebo-controlled Phase 3 efficacy clinical trial and an open-label, long-term, safety study of AP in patients with MS. Favorable results from these studies could lead to the filing of a new drug application (NDA) with the FDA under Section 505(b)(2) seeking approval of AP for the treatment of spasticity.

Ronald W. Barrett, chief executive officer of XenoPort, stated, “In our previous Phase 2 clinical trial in spinal cord injury patients with spasticity, AP was well tolerated and demonstrated dose-dependent improvement in muscle tone that was maintained throughout the twelve-hour dosing interval. We hope to demonstrate similar results in our Phase 3 trial of AP in MS patients with spasticity.”

Randall Schapiro, M.D., Clinical Professor of Neurology at the University of Minnesota and President of the Schapiro Multiple Sclerosis Advisory Group, stated, “Available treatments do not fully address the needs of MS patients with spasticity. Baclofen is often used in these patients, but its short duration of action and central nervous system side effects can result in sub-optimal therapy. A new oral medicine that could maintain efficacy with limited adverse events would be a welcome addition to the spasticity treatment armamentarium.”

XenoPort intends to initiate this Phase 3 clinical program in the first half of 2011. The pivotal trial would be a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as a treatment for spasticity in MS patients. Patients who complete this study would have the option to enter a long-term study to evaluate the safety of AP in MS patients. Following successful outcomes from these studies, XenoPort would file an NDA with the FDA using the 505(b)(2) application process. The 505(b)(2) application would enable XenoPort to reference published literature and the FDA’s previous finding of safety and effectiveness for baclofen, a drug that has been approved by the FDA for the alleviation of signs and symptoms of spasticity resulting from MS.

About Arbaclofen Placarbil (AP)

AP is a patented new chemical entity that is a Transported Prodrug of R-baclofen designed to engage natural nutrient transport mechanisms found on intestinal cell membranes, thereby gaining efficient entrance into the bloodstream. AP is then rapidly converted by high-capacity enzymes to the parent compound and natural substances with favorable safety characteristics. R-baclofen is an agonist of the target known as gamma amino-butyric acid(B), or GABA(B), receptor. Baclofen, which is a mixture of the R- and S-isomers, is an approved treatment for spasticity that is administered three or four times a day.

XenoPort has completed a successful Phase 2 clinical trial of AP in patients with spasticity due to spinal cord injury. AP treatment was associated with statistically significant differences from placebo at all time points in the 20 mg and 30 mg twice-a-day AP dose cohorts. AP was well tolerated at all dose levels.

About Spasticity

Spasticity is a debilitating condition that is associated with some common neurological disorders, such as MS, stroke and cerebral palsy, as well as spinal cord injury. The underlying cause of spasticity is unknown, but it is believed to result from an imbalance of inhibitory and excitatory functioning within the central nervous system. Patients with spasticity may experience abnormal increases in muscle tone that are associated with loss of range of motion, increased muscle stretch reflexes, weakness and problems with coordination. Common complications of spasticity include joint and muscle contracture, pain and difficulty performing activities of daily living.

According to “We Move”, a non-profit organization providing patient information and continuing medical education to professionals, two out of every 1,000 people in North America suffer from MS and roughly 200,000 people in the United States suffer from spinal cord injury. It is estimated that spasticity affects between 37% and 78% of MS patients and 40% of spinal cord injury patients.

About XenoPort

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is collaborating with Astellas Pharma Inc. and GlaxoSmithKline to develop and commercialize XP13512, its lead product candidate. XenoPort’s product candidates are being studied for the potential treatment of restless legs syndrome, gastroesophageal reflux disease, neuropathic pain, spasticity and Parkinson’s disease. To learn more about XenoPort, please visit the web site at www.XenoPort.com.

Forward-Looking Statements

This press release contains “forward-looking” statements, including, without limitation, all statements related to the potential of AP as a treatment of spasticity in MS patients; XenoPort’s planned AP clinical development program and the timing and the results thereof; planned clinical trial designs; the potential for the filing of an NDA with the FDA under Section 505(b)(2); and the suitability of AP as a treatment for spasticity. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “believe,” “could,” “expects,” “hope,” “intends,” “may,” “planning,” “plans,” “potential,” “would” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon XenoPort’s current expectations. Forward-looking statements involve risks and uncertainties. XenoPort’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the uncertain results and timing of clinical trials; XenoPort’s ability to successfully conduct clinical trials in the anticipated timeframes, or at all; the uncertainty of the FDA’s regulatory process, including uncertainty as to whether the FDA would approve an NDA filed under Section 505(b)(2); XenoPort’s dependence on its current and additional collaborative partners; and the therapeutic and commercial value of XenoPort’s product candidates. These and other risk factors are discussed under the heading “Risk Factors” in XenoPort’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed with the Securities and Exchange Commission on August 6, 2010. XenoPort expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

XenoPort and Transported Prodrug are trademarks of XenoPort, Inc.

Optical Cable Corporation (OCCF) Reports Fiscal Third Quarter 2010 Financial Results

ROANOKE, Va., Sept. 13 /PRNewswire-FirstCall/ — Optical Cable Corporation (Nasdaq: OCCF) (“OCC” or the “Company”) today announced financial results for its fiscal third quarter ended July 31, 2010.  The Company achieved significant increases in net sales and gross profit for both the quarter and year-to-date periods compared to the same periods in fiscal 2009, and returned to profitability in the third quarter of fiscal 2010.

Third Quarter 2010 Financial Results

Net sales during the third quarter of fiscal year 2010 were the highest in OCC’s history — exceeding the quarterly net sales that OCC achieved in the fourth quarter of fiscal year 2008.

Consolidated net sales for the third quarter of fiscal year 2010 increased 32.2% to $18.8 million compared to consolidated net sales of $14.2 million for the comparable period last year.  Net sales growth during the third quarter was achieved over a broad customer base and product mix, with notable increases in both commercial and specialty markets, despite the difficult economic environment.  The acquisition of Applied Optical Systems, Inc. (“AOS”) by OCC on October 31, 2009 also contributed to the net sales growth achieved by the Company for the third quarter of fiscal year 2010.

Net sales of OCC’s fiber optic cable and enterprise connectivity products increased 14.9% and 28.7%, respectively, during the third quarter of fiscal 2010, compared to the same period last year.  Net sales of OCC’s applied interconnect system products (added to OCC’s product offering following the Company’s acquisition of AOS) improved during the third quarter of fiscal 2010 compared to the first and second quarters of fiscal 2010.

Geographically, OCC achieved consolidated net sales growth both in international markets and within the United States during the third quarter of fiscal year 2010.  Net sales to customers located outside of the United States increased 83.6% in the third quarter of fiscal 2010 compared to the same period last year, and net sales to customers located in the United States increased 17.3% as compared to the same period last year.

Gross profit increased 51.8% to $6.8 million in the third quarter of fiscal 2010, compared to $4.5 million in the third quarter of fiscal 2009.  Gross profit margin, or gross profit as a percentage of net sales, increased to 36.2% in the third quarter of fiscal 2010 from 31.6% in the third quarter of fiscal year 2009.

OCC recorded net income attributable to the Company of $575,000, or $0.09 per basic and diluted share, for the third quarter of fiscal year 2010, compared to a net loss of $1.1 million, or $0.19 per basic and diluted share, for the same period last year.

Fiscal Year-to-Date 2010 Financial Results

Consolidated net sales for the first nine months of fiscal 2010 increased 10.2% to $49.0 million compared to net sales of $44.5 million for the same period in fiscal 2009. Net sales in both the Company’s commercial markets and its specialty markets increased during the first nine months of fiscal year 2010 compared to the same period last year.  The acquisition of AOS by OCC on October 31, 2009 also contributed to the net sales growth achieved by the Company for the first nine months of fiscal year 2010.

Based on year-to-date results, OCC expects that net sales for the fiscal year ending October 31, 2010 will be the highest in the Company’s 27 year history.

Gross profit increased 10.7% to $16.6 million in the first nine months of fiscal 2010, compared to $15.0 million for the same period last year.  Gross profit margin, or gross profit as a percentage of net sales, increased slightly to 33.8% in the first nine months of fiscal 2010 compared to 33.7% for the first nine months of fiscal 2009.

For the first nine months of fiscal 2010, OCC recorded a net loss attributable to the Company of $7.2 million, or $1.21 per basic and diluted share, compared to a net loss of $1.8 million, or $0.33 per basic and diluted share, for the first nine months of fiscal 2009.   Significantly contributing to the net loss for the first nine months of fiscal 2010 was a non-recurring, non-cash impairment charge of $6.2 million recorded in the second fiscal quarter to write-off the carrying value of the goodwill associated with the acquisition of AOS.

Excluding the non-recurring, non-cash goodwill impairment charge, the Company would have reported a net loss attributable to OCC of $960,000, or $0.16 per share, for the first nine months of fiscal 2010(1).

Management’s Comments

Neil Wilkin, President and Chief Executive Officer of OCC, said, “Over the past year, OCC has taken steps to grow both organically and through strategic acquisitions in order to offer a comprehensive suite of products to meet the full range of our customers’ needs.  We are pleased to report that these strategic investments are already bearing fruit, as evidenced by the fact that OCC returned to profitability in our third quarter and generated the highest quarterly net sales in the Company’s history.  At the same time, and while maintaining our customer focus, we have significantly improved our cost structure and enhanced our financial flexibility.”

Mr. Wilkin added, “Importantly, we believe our results in the third quarter underscore the strong operating leverage OCC has in its business model–providing OCC with the ability to substantially increase earnings as net sales grow.  Further, we believe we are now beginning to realize product line synergies from our strategic acquisitions.  As a result of our strategic initiatives, we believe OCC is exceptionally well-positioned in our target markets with a full suite of high quality products that provide our customers with unrivaled integrated solutions.  We look forward to continuing to build on OCC’s strong momentum by meeting and exceeding the needs of customers with the goal of creating long-term value for the Company’s shareholders.”

Company Information

Optical Cable Corporation is a leading manufacturer of a broad range of fiber optic and copper data communications cabling and connectivity solutions primarily for the enterprise market, offering an integrated suite of high quality, warranted products which operate as a system solution or seamlessly integrate with other providers’ offerings.  OCC’s product offerings include designs for uses ranging from commercial, enterprise network, datacenter, residential and campus installations to customized products for specialty applications and harsh environments, including military, industrial, mining and broadcast applications.  OCC products include fiber optic and copper cabling, fiber optic and copper connectors, specialty fiber optic and copper connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multi-media boxes and other cable and connectivity management accessories, and are designed to meet the most demanding needs of end-users, delivering a high degree of reliability and outstanding performance characteristics.

OCC is internationally recognized for pioneering the design and production of fiber optic cables for the most demanding military field applications, as well as of fiber optic cables suitable for both indoor and outdoor use, and creating a broad product offering built on the evolution of these fundamental technologies.  OCC also is internationally recognized for its role in establishing copper connectivity data communications standards, through its innovative and patented technologies.

Founded in 1983, OCC is headquartered in Roanoke, Virginia with offices, manufacturing and warehouse facilities located in each of Roanoke, Virginia, near Asheville, North Carolina and near Dallas, Texas.  OCC primarily manufactures its fiber optic cables at its Roanoke facility which is ISO 9001:2008 registered and MIL-STD-790F certified, its enterprise connectivity products at its Asheville facility which is ISO 9001:2008 registered, and its military and harsh environment connectivity products and systems at its Dallas facility which is MIL-STD-790F certified.

Optical Cable Corporation, OCC, Superior Modular Products, SMP Data Communications, Applied Optical Systems, and associated logos are trademarks of Optical Cable Corporation.

Further information about OCC is available on the Internet at www.occfiber.com.

(1) This proforma net loss and net loss per share attributable to OCC are calculated by adding the impairment charge of $6.2 million to the Company’s net loss attributable to OCC as reported for the nine months ended July 31, 2010.  There is no tax benefit associated with the impairment charge, as it is considered a non-deductible permanent item for tax purposes, so there is no change to the tax benefit as reported for the period in determining the proforma net loss and net loss per share attributable to OCC.

FORWARD-LOOKING INFORMATION

This news release by Optical Cable Corporation and its subsidiaries (collectively, the “Company” or “OCC”) may contain certain forward-looking information within the meaning of the federal securities laws. The forward-looking information may include, among other information, (i) statements concerning the Company’s outlook for the future, (ii) statements of belief, anticipation or expectation, (iii) future plans, strategies or anticipated events, and (iv) similar information and statements concerning matters that are not historical facts. Such forwardlooking information is subject to variables, uncertainties, contingencies and risks that may cause actual events to differ materially from the Company’s expectations.  Additionally, such variables, uncertainties, contingencies and risks may adversely affect the Company and the Company’s future results of operations and future financial condition.  Factors that could cause or contribute to such differences from the Company’s expectations or could adversely affect the Company, include, but are not limited to: the level of sales to key customers, including distributors; timing of certain projects and purchases by key customers; the economic conditions affecting network service providers; corporate and/or government spending on information technology; actions by competitors; fluctuations in the price of raw materials (including optical fiber, copper, gold and other precious metals, and plastics and other materials affected by petroleum product pricing); fluctuations in transportation costs; the Company’s dependence on customized equipment for the manufacture of its products and a limited number of production facilities; the Company’s ability to protect its proprietary manufacturing technology; the Company’s ability to replace royalty income as existing patented and licensed products expire by developing and licensing new products; market conditions influencing prices or pricing; the Company’s dependence on a limited number of suppliers; the loss of or conflict with one or more key suppliers or customers; an adverse outcome in litigation, claims and other actions, and potential litigation, claims and other actions against the Company; an adverse outcome in regulatory reviews and audits and potential regulatory reviews and audits; adverse changes in state tax laws and/or positions taken by state taxing authorities affecting the Company; technological changes and introductions of new competing products; changes in end-user preferences for competing technologies, relative to the Company’s product offering; economic conditions that affect the telecommunications sector, certain technology sectors or the economy as a whole; changes in demand of our products from certain competitors for which we provide private label connectivity products; terrorist attacks or acts of war,  and any current or potential future military conflicts; changes in the level of military spending by the United States government; ability to retain key personnel; inability to recruit needed personnel; poor labor relations; the inability to successfully integrate the operations of the Company’s new subsidiaries; the impact of changes in accounting policies, including those by the Securities and Exchange Commission and the Public Company Accounting Oversight Board; the Company’s ability to continue to successfully comply with, and the cost of compliance with, the provisions of Section 404 of the Sarbanes-Oxley Act of 2002 or any revisions to that act which apply to the Company; the impact of changes and potential changes in federal laws and regulations adversely affecting our business and/or which result in increases in our direct and indirect costs as we comply with such laws and regulations; impact of future consolidation among competitors and/or among customers adversely affecting the Company’s position with its customers and/or its market position; actions by customers adversely affecting the Company in reaction to the expansion of its product offering in any manner, including, but not limited to, by offering products that compete with its customers, and/or by entering into alliances with, making investments in or with, and/or acquiring parties that compete with and/or have conflicts with customers of the Company; adverse reactions by customers, vendors or other service providers to unsolicited proposals regarding the management of the Company, and the additional costs of considering and possibly defending the Company’s position on such unsolicited proposals; impact of weather or natural disasters in the areas of the world in which the Company operates and markets its products; economic downturns and/or changes in market demand, exchange rates, productivity, or market and economic conditions in the areas of the world in which the Company operates and markets its products, and the Company’s success in managing the risks involved in the foregoing. The Company cautions readers that the foregoing list of important factors is not exclusive.  Furthermore, the Company incorporates by reference those factors included in current reports on Form 8-K, in the annual report on Form 10-K for the fiscal year ended October 31, 2009, and/or in the Company’s other filings.

Eyak Technology, LLC Announces Cash Offer of $7.00 Per Share for GTSI Corp. (GTSI)

DULLES, Va., Sept. 13 /PRNewswire/ — Eyak Technology, LLC (EyakTek) announced today that it has again made a proposal to the board of directors of GTSI Corp. (Nasdaq: GTSI) to acquire by merger all of the outstanding capital stock of GTSI at a price of $7.00 per share in cash.  The proposal represents a premium of 35.1% over GTSI’s closing market price on September 10, 2010 of $5.18 and a premium of 34.6% over the average closing price for the preceding 30 trading days.

The proposal, which was initially made on August 13, 2010, was reiterated in a letter sent by EyakTek today to GTSI’s board of directors (which letter is included at the end of this press release) after several unsuccessful attempts to engage GTSI in substantive negotiations.  GTSI rejected EyakTek’s proposal in a letter dated August 30, 2010.

EyakTek intends, following the acquisition, to operate GTSI on a standalone basis, in order to preserve and capitalize on its strong brand name and industry recognition.

EyakTek anticipates financing the transaction with a combination of cash on hand and additional senior debt financing, for which it has a commitment, subject to customary conditions.  Houlihan Lokey is acting as financial advisor to EyakTek and Morrison & Foerster LLP is acting as legal advisor to EyakTek.

EyakTek is an Alaska Native-owned small business that provides award-winning solutions in infrastructure and security systems, communications, information technology, and healthcare services.  As a recognized leader in the industry, EyakTek has consistently been ranked as one of the Top 100 Federal Contractors.

For information please call Andrea Williams at 703-880-5308 or visit the Company’s website at www.eyaktek.com.

Below is the full text of the letter sent by EyakTek to GTSI today:

September 13, 2010

VIA EMAIL AND OVERNIGHT MAIL

Gentlemen:

Let me first thank you for the opportunity to meet with members of your Special Committee on August 30, 2010 to discuss the proposal Eyak Technology, LLC (“EyakTek”) made on August 13, 2010 to acquire GTSI Corp. (“GTSI”), and for subsequently making GTSI’s financial advisor available to discuss our proposal with EyakTek’s financial advisor.

During those conversations, we presented an opportunity for your stockholders to achieve liquidity for their shares at a substantial premium.  This may be an especially important opportunity for your stockholders given the extreme illiquidity of GTSI’s stock.  We believe that continuing those discussions on a confidential basis with a goal of reaching a negotiated agreement would be the most desirable course for everyone involved.  As we indicated during our discussions, we are keenly interested in understanding the Special Committee’s underlying rationale on the value of GTSI shares.  We were thus disappointed that you instead chose precipitously to end that dialogue and raise a number of meritless issues regarding GTSI’s minority position in EyakTek that raise concerns about their use as a device to deprive GTSI stockholders of the opportunity to independently evaluate and consider our proposal.  Because we believe our proposal to acquire GTSI is one GTSI’s stockholders would enthusiastically support, we feel compelled to make its existence public.

As you know, on August 13, EyakTek sent GTSI a letter proposing to acquire all outstanding shares of GTSI for $7.00 per share in cash.  On that date, our proposal represented a premium of 36.5% to GTSI’s closing stock price on August 12, 2010 of $5.13 and a 31.3% premium to GTSI’s volume weighted average price of $5.33 for the 30 trading days then ended.  As of the date of this letter, our proposal continues to offer exceptional value to GTSI stockholders, representing similar premiums to the current and average trading prices of GTSI’s stock.

Based on EyakTek’s long relationship with GTSI and our knowledge of the sector, we believe our proposal gives generous credit to the future prospects of GTSI.  In offering GTSI’s stockholders a substantial and immediate economic benefit, our proposal represents a unique opportunity for all GTSI stockholders to maximize and realize the value of their investment.  The transaction we propose would constitute a direct realization event for them, as opposed to the speculative benefit that might be achieved by GTSI continuing on a standalone basis or following any alternative transaction.  Even if GTSI were to deliver operational improvements, the ability of its stockholders to realize value in cash would be dependent on an extraordinary corporate transaction, given GTSI’s average trading volume of just over 4,000 shares a day.  As fiduciaries, you must recognize that our proposal would enable GTSI stockholders to realize a value for their shares that, given GTSI’s current course, is unlikely to be available to them in the marketplace or in the context of another transaction.

We believe that EyakTek’s proposal is particularly compelling in light of the strong headwinds GTSI now faces as a result of the company’s decision to strongly deemphasize the historical product business and convert the company to a services platform.  Assuming that change in strategy can even be successful (which to date it has been far from), GTSI’s own management estimates the company will likely not achieve the goal it has set for the new business model until 2014 at the earliest.  In fact, GTSI’s predicament would be considerably worse were it not for the fact of EyakTek’s own success, since GTSI’s underperformance has been so significantly offset by its equity interest in EyakTek.

We are also acutely aware of the sweeping changes that have occurred in the defense procurement and services industry, and the need to constantly adapt to those changes.  Our industry’s recent history is littered with companies that have failed to respond to the changing requirements of the marketplace.  We believe that our operational expertise, coupled with the strategic benefits of a rationalized business plan leveraging the company’s enhanced capabilities and reach, would finally allow GTSI to achieve its potential.  In our August 30 meeting and subsequent discussions, we explored a wide range of topics, all of which lead to the conclusion that, given the complimentary nature of our two companies, the merits of a strategic transaction are compelling.

As we indicated in our August 13 letter, we anticipate financing the transaction contemplated by our proposal with a combination of cash on hand and additional senior debt financing, with respect to which we have a commitment, subject to customary conditions, for the entirety of the additional funds we will require to consummate the transaction.

We recognize that you must consider what alternatives, if any, may be available to GTSI and its stockholders, and understand that you may wish to solicit other acquisition proposals or explore other strategic alternatives.  While we are confident that our proposal will prove to be the most advantageous to GTSI, its stockholders and its other constituencies, we support you in that process as a way to ensure the best outcome for GTSI’s stockholders.  To address any concerns you may have in that regard, we would anticipate that the definitive agreement for a transaction with EyakTek would contain a “go-shop” provision permitting you to solicit alternative offers to acquire GTSI.  This structure has been used by many public boards of directors and we propose that the definitive agreement for our transaction contain the same “go-shop” structure as was recently adopted by the board of directors of your industry peer, DynCorp International Inc., in its agreement to be acquired by Cerberus Capital Management.

We are very enthusiastic about the mutual benefits of a transaction between our two companies and believe that you should be as well.  Our objective continues to be a negotiated transaction that is supported by you, as well as your stockholders and other stakeholders.  We and our advisors remain ready to reengage with your representatives, so as to promptly move forward with discussions of a definitive agreement and begin our joint effort to create the successful enterprise you and I discussed.  I trust you would agree that it is in the best interests of all GTSI stockholders for you to return to the negotiating table and explore our proposal more fully.

I am sure you appreciate the seriousness of EyakTek’s proposal.  Because of its importance to both of our companies, I look forward to your earliest possible response.  I hope that you will now give our proposal additional consideration.  Indeed, we believe you will determine you have a fiduciary obligation to do so.  Because of that, I remain convinced that, once you have undertaken a further review of our proposal, you will share in our vision and will choose to act in the best interests of your stockholders.

Sincerely,

Otix Global, Inc. (OTIX) Enters Into Definitive Merger Agreement With William Demant Holding A/S

SALT LAKE CITY, Sept. 13 /PRNewswire-FirstCall/ — Otix Global, Inc. (Otix) (Nasdaq: OTIX), a leading provider of hearing care services and solutions and the parent company of Sonic Innovations, Inc. (Sonic) and HearingLife, today announced that it has entered into a definitive merger agreement with William Demant Holding A/S (WDH), the parent company of hearing aid companies, Oticon and Bernafon.  Under the merger agreement WDH will pay $8.60 for each outstanding share of Otix common stock.

“In a short period of time, Otix Global has grown from an innovative start-up company to a leading manufacturer and distributor of superior hearing solutions under its Sonic and HearingLife brands.  Our product lines have garnered industry attention and awards and are representative of the innovative technology for which Otix is known,” said Otix Chairman and CEO Sam Westover.  “The merger with William Demant will provide the research and development, marketing and sales support and resources necessary to further expand Sonic and HearingLife’s presence in the hearing healthcare industry.”

The proposed transaction represents a 112% and 125% premium to Otix’s 5-day and 30-day average stock prices, respectively, as of the last trading day before the merger announcement.  The boards of directors of Otix and WDH have given their approvals to the transaction, which is subject to German and Australian merger control regulations, and other customary closing conditions. The agreement will require the approval of Otix’s shareholders.  It is anticipated that the merger will be completed between mid-November and the end of 2010.

“Otix is proud of the many achievements and contributions it has made to the hearing aid industry.  As a pioneer to the industry, many of Otix Global’s technologies have become standard in the industry today.  The company’s commitment to manufacture and market products to improve the hearing of millions of people worldwide will only be strengthened by the merger,” said Mr. Westover.

ABOUT OTIX GLOBAL:

Otix Global designs, develops, manufactures and markets advanced digital hearing aids designed to provide the highest levels of satisfaction for hearing impaired consumers.

Any statements in this press release about future expectations, plans and prospects for Otix, including statements about the expected timetable for consummation of the proposed transaction among WDH and Otix, and any other statements about WDH’s or Otix’s future expectations, beliefs, goals, plans or prospects, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may contain the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties that are subject to change based on factors that are, in many instances, beyond the control of WDH and Otix. Risks and uncertainties that could cause results to differ from expectations include: the merger may not be approved by our shareholders or the applicable governmental agencies; we may fail to receive the requisite number of votes or proxies from our shareholders to obtain a quorum; the merger agreement may be terminated according to its terms prior to the finalization of the merger; the announcement of the pending merger with WDH may have a significant and deleterious effect on our business; the occurrence of any event or proceeding that could give rise to the termination of the merger agreement; the inability to complete the merger due to the failure of the closing conditions to be satisfied; the outcome of any legal proceedings that may be instituted in connection with the merger; uncertainties as to the timing of the merger; the risk that competing offers will be made; the effects of disruption from the transaction making it more difficult to maintain relationships with employees, customers, suppliers, banking partners, other business partners or governmental entities; other business effects, including the effects of industry, economic or political conditions outside of the control of WDH and Otix; transaction costs; actual or contingent liabilities; or other risks and uncertainties described in the section titled “Risk Factors” in Otix’s Annual Report on Form 10-K for the year ended December 31, 2009, as filed by Otix with the Securities and Exchange Commission, and described in other filings made by Otix from time to time with the Securities and Exchange Commission.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.

Datawatch Corp. (DWCH) Appoints David C. Mahoney to Board of Directors

Sep. 10, 2010 (Business Wire) — Datawatch Corporation (NASDAQ: CM: DWCH), a leader in Business Intelligence (BI), today announced the appointment of David C. Mahoney to the Datawatch Board of Directors.

Mr. Mahoney is a recognized entrepreneur, executive and early stage investor in the software industry. He began his career developing software at MIT Lincoln Labs and in 1973 he joined Data General where he spent 10 years leading the design and development of communications, networking and workstation products. In 1983, Mr. Mahoney founded Banyan Systems, the first software company to create a comprehensive enterprise networking solution that integrated mainframes, minicomputers and personal computers. Within one year, the company delivered the innovative VINES Operating System, Banyan Network Server and Streettalk, the first commercially available enterprise wide directory service. Banyan went public in 1992 and grew its revenues to more than $150 million. Under Mr. Mahoney’s leadership, the company later created Switchboard, an Internet white/yellow pages service which grew to become jointly funded by AOL and CBS and went public in 1999.

In 2003, Mr. Mahoney became CEO of Applix, Inc. and led a restructuring that enabled the company to attain a sustained growth rate in excess of 35 percent annually and resulted in a successful merger in 2007 with Cognos, Inc. During his tenure at Applix, the company achieved a twenty times increase in market valuation. Mr. Mahoney continues to work with venture firms and their early to mid-stage companies as a key board member, advisor or investor, and is currently a director in several U.S. and Canada-based software companies where he works with management and boards to develop and execute growth strategies, secure funding, expand management teams and develop strategic relationships.

“We are delighted that David Mahoney has joined our Board of Directors,” said Richard de J. Osborne, Chairman of Datawatch’s Board of Directors. “David is a highly respected leader and a savvy investor with a long and successful track record working with public and private companies across a broad spectrum of software and technology industries. His participation on our board will provide additional financial expertise and business acumen to help Datawatch increase its leadership position in the business intelligence market and enhance shareholder value.”

Commenting on his appointment, Mr. Mahoney said, “I am very excited to be involved with Datawatch at this time in its history. Businesses more than ever require innovative, cost effective means to enable them to make good business decisions. The company offers a truly unique value proposition to its customers with its suite of easy-to-use, rapid time to implementation BI solutions. Datawatch has a solid infrastructure to support domestic and global opportunities in business intelligence, data transformation and analytics. I look forward to working with the Board of Directors to accelerate the company’s growth and the adoption of its BI solutions.”

Mr. Mahoney holds a BA in Biology from Merrimack College. He is a founding member of the Mass Software Council and of the Common Angels, a Boston based angel investing fund, and has been a member of various local advisory boards with organizations such as the Mass Telecommunications Council, Babson College and Clark University Graduate School of Management.

ABOUT DATAWATCH CORPORATION

Datawatch Corporation (NASDAQ-CM: DWCH), a leader in Business Intelligence (BI), helps companies make better decisions and solve business problems by simplifying access to and analysis of information. Unique among BI vendors, Datawatch transforms the massive amounts of data and documents generated inside or outside a company into actionable insight, without any changes needed to existing systems. Datawatch customers benefit from the right information, in the right context, at the right time. More than 40,000 organizations worldwide rely on Datawatch products including its market-leading Monarch report and data mining solutions. Datawatch is based in Chelmsford, Mass., with offices in London, Sydney and Manila. For more information, visit www.datawatch.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any such statements, including but not limited to those relating to results of operations net of any impairment charges, contained herein are based on current expectations, but are subject to a number of risks and uncertainties that may cause actual results to differ materially from expectations. The factors that could cause actual future results to differ materially from current expectations include the following: risks associated with the uncertainty of the current economic climate; risks associated with fluctuations in quarterly operating results, including results of large transactions occurring within a particular period; Datawatch’s dependence on its principal products; risks associated with international sales and operations, including currency translation risks; risks associated with distributor sales; risks associated with acquisitions; an unfavorable result in any litigation; market acceptance of new products; dependence on the introduction of new products and possible delays in those introductions. Further information on factors that could cause actual results to differ from those anticipated is detailed in various publicly-available documents, which include, but are not limited to, filings made by Datawatch from time to time with the Securities and Exchange Commission, including but not limited to, those appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2009 and Form 10-Q for the quarters ended December 31, 2009, March 31, 2010 and June 30, 2010. Any forward-looking statements should be considered in light of those factors.

© 2010 Datawatch Corporation. Datawatch, Monarch and their respective logos are trademarks or registered trademarks of Datawatch Corporation in the United States and/or other countries. All other names are trademarks or registered trademarks of their respective companies.

Credo Petroleum (CRED) Announces Highest Initial Test Rate in Company History

DENVER, Sept. 9, 2010 (GLOBE NEWSWIRE) — Credo Petroleum Corporation (Nasdaq:CRED), an oil and gas exploration and production company with significant operations in the Williston Basin, Central Kansas and Oklahoma, today provided an update on its North Dakota Bakken horizontal drilling program.

WEISZ 11-14#1-H (“WEISZ”) WELL SUCCESSFULLY COMPLETED

Credo’s second Bakken well has been successfully completed and production tested at high rates. During testing, the Weisz 11-14#1-H (“Weisz”) flowed over 2,000 barrels of oil equivalent from 37 fracture-stimulated stages of Middle Bakken perforations during an early 24-hour period. Brigham Exploration is the operator and Credo owns a 6% working interest. In coming weeks, Brigham will announce the well’s exact initial flow rate, but Credo has confirmed through internal calculations that the official initial rate will in fact exceed 2,000 barrels of oil equivalent, marking the highest initial test rate of any well in which Credo has participated in the company’s 32 year history.

The Weisz well is located on a 1,280 acre spacing unit about one mile east of Brigham’s Olson 10‑15-H well which has produced 126,000 barrels of oil equivalent in 18 months. Based on Brigham’s exploration plan for the area, up to three Bakken wells are expected to be drilled on the spacing unit and potentially three additional wells to develop the deeper Sanish/Three Forks formation.

MANAGEMENT COMMENT

Marlis E. Smith, Jr., Chief Executive Officer, said, “I am extremely pleased with the test results of the Weisz, and the initial flow rate record it has set for Credo. Since joining the Board in April of 2009, I have been a staunch advocate of the Bakken, and targeted acquisition of this specific Bakken acreage with our technical team soon after becoming CEO earlier this year. This particular spacing unit could one day see up to six horizontal wells, two additional Bakken wells, and three Sanish/Three Forks wells. Along with the Bakken, the Sanish/Three Forks is highly prospective in the area.

Smith continued, “We look forward to releasing future Bakken well results, including our previously reported Petro-Hunt 1-H well, which is currently in the final stages of completion, and a well in which Credo owns an 18.75% working interest.”

About Credo Petroleum: Credo Petroleum Corporation is an independent exploration, development and production company based in Denver, Colorado. The company has significant operations in the Williston Basin of North Dakota, central Kansas, the Anadarko Basin of North Texas and northwest Oklahoma, and in southern Oklahoma. Credo uses advanced technologies to systematically explore for oil and gas and, through its patented Calliope Gas Recovery System, to recover stranded reserves from depleted gas reservoirs.

This press release includes certain statements that may be deemed to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements included in this press release, other than statements of historical facts, address matters that the company reasonably expects, believes or anticipates will or may occur in the future. Such statements are subject to various assumptions, risks and uncertainties, many of which are beyond the control of the company. Investors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially from those described in the forward-looking statements. Investors are encouraged to read the “Forward-Looking Statements” and “Risk Factors” sections included in the company’s Annual Report on Form 10-K for more information. Although the company may from time to time voluntarily update its prior forward looking statements, it disclaims any commitment to do so except as required by securities laws.

CONTACT:  Credo Petroleum Corporation
          Marlis E. Smith, Jr., Chief Executive Officer
          Alford B. Neely, Chief Financial Officer
          303-297-2200
          www.credopetroleum.com

KIT digital (KITD) Acquires Accela Communications and Megahertz Broadcast Systems

PRAGUE, CZECH REPUBLIC — (Marketwire) — 09/09/10 — KIT digital, Inc. (NASDAQ: KITD), the leading global provider of video asset management solutions (VAMs) for multi-screen IP-based delivery, has acquired Accela Communications, Inc. (based in Southborough, Massachusetts) and the assets of Megahertz Broadcast Systems, Ltd. (based in Ely, United Kingdom).

“These acquisitions extend our leading market share position for enterprise-level video asset management products and services across the multiple screens of the mobile and tablet device, browser and IP-enabled television,” said KIT digital’s chairman and CEO, Kaleil Isaza Tuzman. “They are consistent with our acquisition strategy of geographical and sales vertical expansion, and we expect them to be accretive on both a revenue and cash-flow basis.”

Accela Communications Acquisition
Accela Communications is a privately-held provider of on-demand, video-based enablement and measurement tools.

KIT digital paid consideration of approximately $4.7 million (net of working capital adjustment), comprised of $1.8 million in cash and 332,763 shares of KIT digital common stock. Stock consideration is subject to lock-up provisions, and will help ensure management’s long-term commitment and upside in the combined digital business. Based on its most recent August results, Accela derives in excess of $3.7 million in annualized recurring licensing fees from its interactive video and multimedia software solutions.

“Our acquisition of Accela, while relatively small, is highly synergistic,” said Lou Schwartz, head of the Americas for KIT digital. “Accela enhances KIT digital’s market scope through its deep experience in particular industry vertical segments amongst its client base: healthcare, information technology, and financial services. Accela also adds strong sales channel partnerships. At the same time, KIT digital brings multi-screen VAMs capabilities which can be upsold to Accela’s enterprise customer base, along with other extended solutions and services.”

Accela’s online video platform, AccelaCast, supports the production, delivery and measurement of interactive video and multimedia communications, providing corporate clients greater audience engagement and learning across a wide range of industries.

AccelaCast allows organizations to create unique multimedia programs through customized design, navigation and data collection options. These clients can then manage and monetize those interactions through the AccelaWorks data acquisition, measurement, classification and delivery system.

Accela serves more than 150 corporate customers, including Alcatel-Lucent, CA, EMC, Hitachi Data Systems, Haymarket Medical, HP, IDG, International Medical Press, McAfee, Motorola, Multiple Sclerosis Association of America, Rogers, SAP and Xerox. Accela sells both directly and through value-added reseller relationships — sales channels which will now apply to the broader KIT VX solution set sold by KIT digital.

Bill Reinstein, Accela president and CEO, commented: “We are very excited to be teaming with the global leader in IP video management, particularly given KIT digital’s strong mobile, live event and connected TV delivery capabilities. Our collective strengths should yield exceptional value and unique benefits for our newly combined global customer base. Our organizations also share a customer-centric culture and a disciplined approach to operational and financial management.”

KIT digital will progressively transition Accela’s clients to the data layer of its VX-one software platform, while maintaining AccelaCast’s client-facing reporting, measurement and interactive audience engagement modules.

Southborough, Massachusetts will continue to be home to Accela’s 30+ employees, and will become KIT digital’s New England sales and account management hub.

The acquisition of Accela Communications closed Wednesday, September 8, 2010.

Megahertz Broadcast Systems Acquisition
Megahertz Broadcast Systems is a broadcast video systems integrator, serving leading broadcasters, MSOs and telecommunications providers in advanced digital video and IP-based implementations. Megahertz has particular expertise in complex, in-the-field video capture and distribution systems, including outside-broadcast (OB) vehicles and remote news gatherers.

Under the terms of the acquisition, KIT digital will acquire 100% of Megahertz’s assets from its Canadian parent company, AZCAR Technologies, Inc., in exchange for $2.7 million in net cash and certain stock-based management incentive agreements. Based on its most recent August results, Megahertz derives in excess of $4.5 million in annualized revenues from its long-term client services relationships and maintenance contracts.

“Megahertz is one of the most respected providers in the advanced digital video systems integration market and our respective teams have competed in the market over the years,” said Isaza Tuzman. “This acquisition removes a competitor and extends our existing advanced digital and IP video systems integration capabilities — which support our larger-scale software implementations with broadcasters and network operators. It also underlines our mission of bridging the gap between traditional broadcast and new media for our customers, as we offer global professional service and implementation capabilities which are demanded by large customers and are notably absent in our competitive segment.”

Megahertz has historically been strongest in the Europe, Middle East & Africa (EMEA) zone, and clients include Al Jazeera, APTN (UK), ART, BBC, British Telecom, BSkyB, CNN, eTV (South Africa), Fiji TV, Goldman Sachs, ING Barings, Kuwait TV, Qatar Radio & TV, RTBF, RTE, SIS, Telenor, TF1 and TV4 Sweden.

Tomas Petru, president of integration services at KIT digital, commented: “We plan to cross-sell our VX-one video management platform — with a special focus on mobile video and IPTV cable distribution capabilities — into Megahertz’s existing client base while leveraging Megahertz’s integration and implementation expertise across our largest clients in Western Europe, the Middle East and Africa. Combined with our acquisition of Singapore-based Benchmark Broadcast Systems earlier in the year, the Megahertz acquisition affords additional synergies and gives us a truly global footprint for high-end video asset management deployments for major broadcasters and network operators.”

Frances Jarvis, managing director of Megahertz, said: “This was the right strategic move for us. The broadcast systems integration and IP-based VAMs fields are clearly converging, as the industry as a whole moves to IP-based workflow. KIT digital is emerging as the only company that clearly understands this convergence and is providing end-to-end video management capabilities for industrial-grade users of video. Given our more than two decades of experience serving content owners and network operators globally, we believe the sales synergies and respective strengths in IP video and broadcast technologies between our companies are unique and powerful.”

Ely, UK will continue to be home to Megahertz’s 20+ employees and full-time consultants, and will become an integral part of KIT digital’s existing EMEA sales and account management activities. The companies will be jointly presenting their products and solutions at the annual IBC Conference in Amsterdam, the Netherlands on September 9-14, 2010.

The acquisition of the assets of Megahertz Broadcast Systems is expected to close today Thursday, September 9, 2010.

Pro forma of the issuance of common shares and cash outlay related to the purchase price for these two acquisitions, KIT digital estimates it will have approximately 23.7 million shares outstanding, and hold in excess of $58 million in cash and equivalents. The company expects there will be modest restructuring and integration costs related to the acquisitions, totaling not more than 50% of the original, combined purchase price.

About Accela Communications, Inc.
Accela Communications is a marketing technology company that provides software and services to produce, deliver and measure interactive, IP-based video communications across a wide range of industries including healthcare, information technology, financial services and marketing services. The company creates opportunities for market and audience engagement with the AccelaCast® multimedia platform and the AccelaWorks® data acquisition, measurement, classification and delivery system. The company generates actionable results through its Healthcare Solutions Group for all of the top twenty pharmaceutical companies, as well as for customers like HP, EMC, SAP, Thermo Fisher Scientific and others. For more information about Accela, visit www.accelacommunications.com.

About Megahertz Broadcast Systems, Ltd.
UK-based Megahertz Broadcast Systems is one of the world’s premier independent broadcasting systems integrators. Megahertz experience covers every aspect of systems implementation from engineering planning, project management, design, product evaluation, commissioning, training, support and IT services. Megahertz has completed turnkey projects for some of the world’s leading broadcasters, telecommunication and digital media companies. Megahertz has constructed sophisticated IP-based news gathering solutions and HD broadcast facilities as well as “best of breed” outside broadcast vehicles. For additional information, visit www.megahertz.co.uk.

About KIT digital, Inc.
KIT digital (NASDAQ: KITD) is a leading global provider of video asset management solutions (VAMs) for multi-screen IP-based delivery. KIT VX-one, the company’s family of end-to-end software platform solutions, enables enterprise clients to acquire, manage and distribute video assets across the three screens of today’s world: the personal computer, mobile device, and IPTV-enabled television set. The application of VX ranges from commercial video distribution to internal corporate deployments, including corporate communications, human resources, training, security and surveillance. KIT digital’s client base includes more than 1,000 customers across 40+ countries, including The Associated Press, Best Buy, Bristol-Myers Squibb, Disney-ABC, FedEx, General Motors, Google, Hewlett-Packard, Home Depot, IMG Worldwide, ESPN Star, MediaCorp, News Corp, Telefonica, Verizon and Vodafone. KIT digital is headquartered in Prague, and maintains principal offices in Atlanta, Beijing, Buenos Aires, Cairo, Chennai, Cologne, Delhi, Dubai, Kolkata, London, Melbourne (Australia), Mumbai, New York, Singapore, Stockholm and Toronto. For additional information, visit www.kitd.com or follow the company on Twitter at www.twitter.com/KITdigital.

KIT digital Forward-Looking Statement
This press release contains certain “forward-looking statements” related to the businesses of KIT digital, Inc. which can be identified by the use of forward-looking terminology such as “anticipates,” “believes,” “estimates,” “expects” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development and commercialization, the ability to obtain or maintain patent and other proprietary intellectual property protection, market acceptance, future capital requirements, regulatory actions or delays, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our public filings with the U.S. Securities and Exchange Commission. KIT digital is not under any obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

KIT digital Contact:
Adam Davis
Global Communications Manager
Tel. +1-609-468-9500
Email Contact

KIT digital Investor Relations Contact:
Matt Glover or Geoffrey Plank
Liolios Group, Inc.
Tel. +1-949-574-3860
Email Contact

Tucows (TCX) Announces Intention to Commence a Dutch Auction Tender Offer

TORONTO, Sept. 9 /CNW/ – Tucows Inc. (NYSE AMEX:TCX, TSX:TC) a global provider of domain names, email and other Internet services, announced today that it intends to commence a modified “Dutch auction” tender offer to repurchase up to 2,900,000 shares of common stock, representing approximately 5.1% of Tucows’ outstanding shares. The tender offer is expected to commence on Friday, September 17, 2010 and to expire, unless extended, at 5:00 P.M., New York City Time, on Tuesday, October 19, 2010. Tucows also announced that it has terminated its normal course issuer bid commenced in February 2010 pursuant to which Tucows has repurchased 3,409,300 shares of common stock.

Under the tender offer, shareholders will have the opportunity to tender some or all of their shares at a price within the range of $0.61 to $0.70 per share, which price range may be modified by Tucows prior to the commencement of the offer. On September 8, 2010, the closing price of Tucows common stock on the NYSE Amex was $0.62. Based on the number of shares tendered and the prices specified by the tendering shareholders, Tucows will determine the lowest per share price within the range that will enable it to buy 2,900,000 shares, or such lesser number of shares that are properly tendered. If shareholders of more than 2,900,000 shares properly tender their shares at or below the determined price per share, Tucows will purchase shares tendered by such shareholders, at the determined price per share, on a pro rata basis. Additionally, if more than 2,900,000 shares are properly tendered, the number of shares to be repurchased by Tucows pursuant to the tender offer may, at the discretion of Tucows, be increased by up to 2% of Tucows’ outstanding shares, or approximately 1,147,000 shares, without amending or extending the tender offer.

Shareholders whose shares are purchased in the offer will be paid the determined purchase price per share net in cash, without interest, after the expiration of the offer period. The offer is not contingent upon any minimum number of shares being tendered. The offer is subject to a number of other terms and conditions that will be specified in the offer to purchase that will be distributed to shareholders. The information agent for the offer will be StockTrans, Inc. None of Tucows, its board of directors or the information agent is or will be making any recommendation to shareholders as to whether to tender or refrain from tendering their shares into the tender offer. Shareholders must decide how many shares they will tender, if any, and the price within the stated range at which they will offer their shares for purchase by Tucows.

This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any shares of Tucows’ common stock. The offer will be made solely by the offer to purchase and the related letter of transmittal. Shareholders and investors are urged to read Tucows’ tender offer statement on Schedule TO that will be filed with the Securities and Exchange Commission in connection with the tender offer, which will include exhibits, the offer to purchase and the related letter of transmittal, when available, because they will contain important information. Each of these documents will be filed with the Securities and Exchange Commission, and investors will be able to obtain them for free from the Securities and Exchange Commission at its website (www.sec.gov) or from StockTrans, Inc., the information agent for the tender offer, by directing such request to: StockTrans, Inc., Attn: Re-Organization Dept., 44 West Lancaster Avenue, Ardmore, PA 19003, telephone (800) 733-1121.

About Tucows

Tucows is a global Internet services company. OpenSRS manages over ten million domain names and millions of email boxes through a reseller network of over 10,000 web hosts and ISPs. Hover is the easiest way for individuals and small businesses to manage their domain names and email addresses. YummyNames owns premium domain names that generate revenue through advertising or resale. Butterscotch.com is an online video network building on the foundation of Tucows.com. More information can be found at http://tucowsinc.com

This news release contains, in addition to historical information, forward-looking statements related to the proposed tender offer, including the timing, total number of shares to be purchased under the proposed tender offer and the process for the proposed tender offer. Such statements are based on management’s current expectations and are subject to a number of uncertainties and risks, which could cause actual results to differ materially from those described in the forward-looking statements. Information about potential factors that could affect Tucows’ business, results of operations and financial condition is included in the Risk Factors sections of Tucows’ filings with the Securities and Exchange Commission. All forward-looking statements included in this document are based on information available to Tucows as of the date of this document, and except to the extent Tucows may be required to update such information under any applicable securities laws, Tucows assumes no obligation to update such forward-looking statements.

TUCOWS is a registered trademark of Tucows Inc. or its subsidiaries. All other trademarks and service marks are the properties of their respective owners.

BSD Medical’s (BSDM) China Distributor Orders Two BSD-2000 Hyperthermia Systems

Sep. 9, 2010 (Business Wire) — BSD Medical Corporation (NASDAQ: BSDM) (the “Company” or “BSD”) announced today that Dalian Orientech Co. Ltd (“Orientech”), the Company’s exclusive China distributor, has ordered two BSD-2000 Hyperthermia Systems (BSD-2000). The BSD-2000 System utilizes BSD’s proprietary synchronous phased array technology to non-invasively target therapeutic heating (hyperthermia) to certain cancerous tumors, including those located deep within the body. Clinical studies have shown that hyperthermia treatment can kill cancer cells directly as well as increase the effectiveness of other cancer therapies, including radiation therapy, for the treatment of certain tumors.

Hyperthermia cancer therapy has a strong following in China, and Orientech controls about 65% of the market. The Orientech sales force covers 23 provinces. After shipping the two systems, the Company will have sold 19 BSD-2000 Hyperthermia Systems to Orientech.

Hyperthermia has been used in China for the treatment of cancer for many years. The hyperthermia market in China has historically been supported by Chinese manufactured systems. The market objective for BSD in China is to continue to expand and upgrade the existing market for clinical hyperthermia equipment to the advanced features of the BSD-2000.

About BSD Medical Corporation

BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals and clearances in the United States, Europe and China. The BSD-2000 is restricted to investigational use in the US. For further information visit BSD Medical’s website at www.BSDMedical.com.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.

Streamline Health (STRM) Document Workflow Solutions Purchased By Tampa-Based Hospital

CINCINNATI, Sept. 8 /PRNewswire/ — Streamline Health Solutions, Inc. (Nasdaq: STRM) a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of Streamline Health’s document workflow solutions to help optimize business processes across the enterprise and improve operational efficiencies. Streamline Health expects at least two of the workflow solutions to be fully implemented and operational prior to the conclusion of the current fiscal year.

“We expect that Streamline Health’s document workflow solutions will be crucial in driving higher levels of productivity and accountability for essential business processes within our customer’s organization,” said J. Brian Patsy, president and chief executive officer of Streamline Health. “We are confident these solutions will meet their specific needs for flexibility, while managing business processes for future growth. The hospital will utilize these workflows to drive operating efficiencies across departments as it continues to enhance productivity and simplify processes.”

The medical institution will leverage its existing Streamline Health technology investments with the implementation of Streamline Health’s business process document workflow solutions as follows:

• Contract Management Workflow automates the business process for managing and tracking contracts, thereby ensuring timely approvals. Authorized users are provided simultaneous access to documents which are retained in a repository that automatically alerts departments when contract renewal dates are fast approaching.
• Application Service Request Workflow enhances and tracks information technology infrastructure requests for increased productivity and cost savings. As a result, hospitals can better control expenditures through automated routing and approval of application service requests across the enterprise i.e. IT equipment, telecommunications, etc.
• Administrative Request Workflow automates manual processes associated with paper forms for tracking approvals, thereby reducing operational costs and improving employee productivity.

Mr. Patsy continued, “We are excited about the opportunity to provide this leading hospital with solutions that offer ease of use, departmental flexibility and a high rate of adoption by hospital personnel. Streamline Health’s business process workflows will boost productivity and contain costs in the very near term with a substantial return on investment. We look forward to expanding our relationship with this valued customer in the coming years.”

About Streamline Health

Streamline Health is a leading supplier of document workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization.  The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, connectivity, optical character recognition (OCR) and business process integration.

Streamline Health’s solutions create a permanent document-based repository of historical health information that is complementary and can be seamlessly integrated with existing disparate clinical, financial and administrative information systems, providing convenient electronic access to all forms of patient information from any location, including secure web-based access. For additional information, please visit our website at http://www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company’s products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company’s ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.